<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open-access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4889076</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0150079</article-id><article-id pub-id-type="publisher-id">PONE-D-15-29515</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Mental Health and Psychiatry</subject><subj-group><subject>Dementia</subject><subj-group><subject>Alzheimer Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Dementia</subject><subj-group><subject>Alzheimer Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Neurodegenerative Diseases</subject><subj-group><subject>Alzheimer Disease</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Classical Mechanics</subject><subj-group><subject>Damage Mechanics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Genome Sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Genome Sequencing</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Computational Neuroscience</subject><subj-group><subject>Coding Mechanisms</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Computational Neuroscience</subject><subj-group><subject>Coding Mechanisms</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Population Groupings</subject><subj-group><subject>Age Groups</subject><subj-group><subject>Elderly</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Catabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Geriatrics</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetic Loci</subject><subj-group><subject>Alleles</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Influence of Coding Variability in APP-A&#x003b2; Metabolism Genes in Sporadic Alzheimer&#x02019;s Disease</article-title><alt-title alt-title-type="running-head">Coding Variability in APP-A&#x000df; Metabolism Genes in Alzheimer's Disease</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sassi</surname><given-names>Celeste</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ridge</surname><given-names>Perry G.</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nalls</surname><given-names>Michael A.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gibbs</surname><given-names>Raphael</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Jinhui</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lupton</surname><given-names>Michelle K.</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Troakes</surname><given-names>Claire</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lunnon</surname><given-names>Katie</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Al-Sarraj</surname><given-names>Safa</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Kristelle S.</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Medway</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lord</surname><given-names>Jenny</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Turton</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><collab>ARUK Consortium</collab><xref ref-type="author-notes" rid="fn001"><sup>&#x000b6;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Morgan</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Powell</surname><given-names>John F.</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kauwe</surname><given-names>John S.</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cruchaga</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bras</surname><given-names>Jose</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Goate</surname><given-names>Alison M.</given-names></name><xref ref-type="aff" rid="aff010"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Singleton</surname><given-names>Andrew B.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guerreiro</surname><given-names>Rita</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hardy</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Reta Lila, Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States of America</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Department of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charite&#x02019; Universit&#x000e4;tmedizin, Berlin, Germany</addr-line></aff><aff id="aff004"><label>4</label><addr-line>German Center for Neurodegenerative Diseases (DZNE), Berlin site, Germany</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Departments of Biology, Neuroscience, Brigham Young University, Provo, UT, United States of America</addr-line></aff><aff id="aff006"><label>6</label><addr-line>King's College London Institute of Psychiatry, London, United Kingdom</addr-line></aff><aff id="aff007"><label>7</label><addr-line>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia</addr-line></aff><aff id="aff008"><label>8</label><addr-line>Translation Cell Sciences-Human Genetics, School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, United Kingdom</addr-line></aff><aff id="aff009"><label>9</label><addr-line>Washington University, Division of Biology and Biomedical Sciences St. Louis, MO, United States of America</addr-line></aff><aff id="aff010"><label>10</label><addr-line>Icahn School of Medicine at Mount Sinai, Icahn Medical Institute, New York, NY, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Iijima</surname><given-names>Koichi M</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>National Center for Geriatrics and Gerontology, JAPAN</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: CS R. Guerreiro ABS JH. Performed the experiments: CS MKL R. Guerreiro KSB. Analyzed the data: CS PGR MAN R. Gibbs R. Guerreiro JD ABS JH. Contributed reagents/materials/analysis tools: ABS JH AMG CC JSK KM JFP. Wrote the paper: CS R. Guerreiro ABS JH. Samples collection: ARUK Consortium SA MKL KL CM KSB CC AMG R. Guerreiro JSK CT JL JB JT ABS JH.</p></fn><fn fn-type="other" id="fn001"><p>&#x000b6; Membership of The Alzheimer&#x02019;s Research UK (ARUK) Consortium is provided in the Acknowledgments</p></fn><corresp id="cor001">* E-mail: <email>j.hardy@ucl.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>1</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>6</issue><elocation-id>e0150079</elocation-id><history><date date-type="received"><day>6</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>9</day><month>2</month><year>2016</year></date></history><permissions><license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0150079.pdf"/><abstract><p>The cerebral deposition of A&#x003b2;<sub>42</sub>, a neurotoxic proteolytic derivate of amyloid precursor protein (APP), is a central event in Alzheimer&#x02019;s disease (AD)(Amyloid hypothesis). Given the key role of APP-A&#x003b2; metabolism in AD pathogenesis, we selected 29 genes involved in APP processing, A&#x003b2; degradation and clearance. We then used exome and genome sequencing to investigate the single independent (single-variant association test) and cumulative (gene-based association test) effect of coding variants in these genes as potential susceptibility factors for AD, in a cohort composed of 332 sporadic and mainly late-onset AD cases and 676 elderly controls from North America and the UK. Our study shows that common coding variability in these genes does not play a major role for the disease development. In the single-variant association analysis, the main hits, none of which statistically significant after multiple testing correction (1.9e<sup>-4</sup>&#x0003c;p-value&#x0003c;0.05), were found to be rare coding variants (0.009%&#x0003c;MAF&#x0003c;1.4%) with moderate to strong effect size (1.84&#x0003c;OR&#x0003c;Inf) that map to genes mainly involved in A&#x003b2; extracellular degradation (<italic>TTR</italic>, <italic>ACE</italic>), clearance (<italic>LRP1</italic>) and APP trafficking and recycling (<italic>SORL1</italic>). These results were partially replicated in the gene-based analysis (c-alpha and SKAT tests), that reports <italic>ECE1</italic>, <italic>LYZ</italic> and <italic>TTR</italic> as nominally associated to AD (1.7e<sup>-3</sup> &#x0003c;p-value &#x0003c;0.05). In concert with previous studies, we suggest that 1) common coding variability in APP-A&#x003b2; genes is not a critical factor for AD development and 2) A&#x003b2; degradation and clearance, rather than A&#x003b2; production, may play a key role in the etiology of sporadic AD.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002283</institution-id><institution>Alzheimer&#x02019;s Research UK</institution></institution-wrap></funding-source></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source></award-group><award-group id="award003"><funding-source><institution>Wellcome Trust/MRC Joint Call in Neurodegeneration Award</institution></funding-source><award-id>WT089698</award-id></award-group><award-group id="award004"><funding-source><institution>National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals</institution></funding-source></award-group><award-group id="award005"><funding-source><institution>the Big Lottery</institution></funding-source><principal-award-recipient><name><surname>Morgan</surname><given-names>Kevin</given-names></name></principal-award-recipient></award-group><award-group id="award006"><funding-source><institution>Alzheimer's Research UK</institution></funding-source><principal-award-recipient><name><surname>Guerreiro</surname><given-names>Rita</given-names></name></principal-award-recipient></award-group><award-group id="award007"><funding-source><institution>Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke</institution></funding-source><award-id>ZO1 AG000950-10</award-id><principal-award-recipient><name><surname>Singleton</surname><given-names>Andrew B.</given-names></name></principal-award-recipient></award-group><funding-statement>This study was supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023), the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). The MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research are jointly funded from ARUK and AS. Tissue samples were supplied by The London Neurodegenerative Diseases Brain Bank, which receives funding from the MRC and as part of the Brains for Dementia Research programme, jointly funded by Alzheimer&#x02019;s Research UK and Alzheimer&#x02019;s Society.</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="4"/><page-count count="14"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The cerebral deposition of A&#x003b2;<sub>42</sub> aggregates, insoluble neurotoxic derived of amyloid precursor protein (APP), is likely caused by an imbalance between A&#x003b2; production and clearance and represents a key event in Alzheimer&#x02019;s disease (Amyloid hypothesis) [<xref rid="pone.0150079.ref001" ref-type="bibr">1</xref>].</p><p>A growing body of evidence has pointed to the critical role of APP-A&#x003b2; metabolism in AD pathogenesis. First, the discovery of <italic>APP</italic>, <italic>PSEN1</italic> and <italic>PSEN2</italic> mutations showed that familial Alzheimer&#x02019;s disease is linked to A&#x003b2;<sub>42</sub> overproduction [<xref rid="pone.0150079.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pone.0150079.ref004" ref-type="bibr">4</xref>]. Second, genome-wide association studies (GWASs) identified several susceptibility loci associated with AD (<italic>APOE</italic>, <italic>BIN1</italic>, <italic>PICALM</italic>, <italic>CD33</italic>, <italic>ABCA7</italic>, <italic>CLU</italic>, <italic>MS4A6A</italic>, <italic>EPHA1</italic>, <italic>CR1</italic>, <italic>CD2AP</italic>, <italic>SORL1</italic>, <italic>CASS4</italic>) and regulating APP-A&#x003b2; levels [<xref rid="pone.0150079.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0150079.ref012" ref-type="bibr">12</xref>]. Third, next generation sequencing laid the ground for the discovery of <italic>TREM2</italic> risk variants, highlighting the possible role of microglia in A&#x003b2; clearance [<xref rid="pone.0150079.ref013" ref-type="bibr">13</xref>&#x02013;<xref rid="pone.0150079.ref014" ref-type="bibr">14</xref>]. Finally, although recent studies have shown that rare coding variability in <italic>PSEN1</italic> may influence the susceptibility for apparently sporadic late-onset AD (LOAD) [<xref rid="pone.0150079.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0150079.ref016" ref-type="bibr">16</xref>], increases in A&#x003b2; production currently explain a minority of AD cases. By contrast, it is very likely that the majority of AD cases are caused by impaired degradation and clearance of A&#x003b2;, which is produced at normal levels throughout life [<xref rid="pone.0150079.ref017" ref-type="bibr">17</xref>&#x02013;<xref rid="pone.0150079.ref018" ref-type="bibr">18</xref>]. Despite the importance of APP-A&#x003b2; metabolism in AD, the role of genes taking part in A&#x003b2; production and catabolism as susceptibility factors for AD is still elusive and has not been extensively investigated. Therefore, in this study, we selected 29 genes known to be involved in APP and A&#x003b2; processing: <italic>ADAM9</italic>, <italic>ADAM10</italic>, <italic>ADAM17</italic>, <italic>MEP1B</italic>, <italic>BACE1</italic>, <italic>BACE2</italic>, <italic>NCSTN</italic>, <italic>PSENEN</italic>, <italic>APH1B</italic>, <italic>LRRTM3</italic>, <italic>APLP1</italic>, <italic>APBA1</italic>, <italic>SORL1</italic>, <italic>TTR</italic>, <italic>GPR3</italic>, <italic>ECE1</italic>, <italic>ECE2</italic>, <italic>IDE</italic>, <italic>CST3</italic>, <italic>CTSB</italic>, <italic>CTSD</italic>, <italic>LYZ</italic>, <italic>MME</italic>, <italic>ACE</italic>, <italic>MMP3</italic>, <italic>A2M</italic>, <italic>PLAT</italic>, <italic>KLK6</italic> and <italic>LRP1</italic>. We then analyzed the single, independent and the cumulative effect of protein coding variants in these genes from exome and genome sequencing data, in a cohort composed of 332 sporadic and mainly late-onset AD cases and 676 elderly controls from North America and UK.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><p>We used exome and genome sequencing data to identify common, low frequency, and rare coding variants in 29 genes involved in: A&#x003b2; production (<italic>ADAM9</italic>, <italic>ADAM10</italic>, <italic>ADAM17</italic>, <italic>BACE1</italic>, <italic>BACE2</italic>, <italic>NCSTN</italic>, <italic>PSENEN</italic>, <italic>APH1B</italic>, <italic>MEP1B</italic>, <italic>LRRTM3</italic>, <italic>GPR3</italic>), APP stabilization (<italic>APLP1</italic>, <italic>APBA1)</italic>, APP recycling (<italic>SORL1</italic>), A&#x003b2; deposition (<italic>TTR</italic>), intracellular degradation (<italic>ECE1</italic>, <italic>ECE2</italic>, <italic>IDE</italic>, <italic>CST3</italic>, <italic>CTSB</italic>, <italic>CTSD</italic>, <italic>LYZ</italic>, <italic>MME)</italic>, extracellular degradation and clearance (<italic>ACE</italic>, <italic>MMP3</italic>, <italic>A2M</italic>, <italic>PLAT</italic>, <italic>KLK6</italic>, <italic>LRP1)</italic>.</p><p>These genes were chosen on the basis of PubMed based literature search and/or based on predicted protein interactions using STRING (<ext-link ext-link-type="uri" xlink:href="http://string.embl.de/">http://string.embl.de/</ext-link>).</p><p>The discovery cohort was composed of 332 apparently sporadic AD cases and 676 elderly controls, neuropathologically and clinically confirmed, originating from the UK and North America. The mean age at disease onset was 71.66 years (range 41&#x02013;94 years) for cases and the mean age of ascertainment was 78.15 years (range 60&#x02013;102 years) for controls (<bold><xref ref-type="table" rid="pone.0150079.t001">Table 1</xref></bold>). The majority of the cases (77%) were late-onset (&#x0003e; 65 years at onset).</p><table-wrap id="pone.0150079.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0150079.t001</object-id><label>Table 1</label><caption><title>Cohort description.</title></caption><alternatives><graphic id="pone.0150079.t001g" xlink:href="pone.0150079.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">COHORTS</th><th align="justify" rowspan="1" colspan="1">N</th><th align="justify" rowspan="1" colspan="1">TYPE</th><th align="justify" rowspan="1" colspan="1">SEQUENCING STRATEGY</th><th align="justify" colspan="2" rowspan="1">ORIGIN</th><th align="justify" rowspan="1" colspan="1">AGE (YRS)</th><th align="justify" rowspan="1" colspan="1">MALE</th><th align="justify" rowspan="1" colspan="1"><italic>APOE</italic></th></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" colspan="2" rowspan="1"/><th align="justify" rowspan="1" colspan="1">MEAN &#x000b1;SD(RANGE)</th><th align="justify" rowspan="1" colspan="1">(%)</th><th align="justify" rowspan="1" colspan="1">E4+ (%)</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>NIH-UCL</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" colspan="2" rowspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">cases</td><td align="justify" rowspan="1" colspan="1">127</td><td align="justify" rowspan="1" colspan="1">neuropath</td><td align="justify" colspan="2" rowspan="1">Exome sequencing</td><td align="left" rowspan="1" colspan="1">Caucasian (British)</td><td align="justify" rowspan="1" colspan="1">65.5(41&#x02013;94)</td><td align="justify" rowspan="1" colspan="1">46.4</td><td align="justify" rowspan="1" colspan="1">58</td></tr><tr><td align="justify" rowspan="1" colspan="1">controls<xref ref-type="table-fn" rid="t001fn002">*</xref></td><td align="justify" rowspan="1" colspan="1">204</td><td align="justify" rowspan="1" colspan="1">neuropath</td><td align="justify" colspan="2" rowspan="1">Exome sequencing</td><td align="left" rowspan="1" colspan="1">Caucasian (British, North American)</td><td align="justify" rowspan="1" colspan="1">79.8 (61&#x02013;102)</td><td align="justify" rowspan="1" colspan="1">58.3</td><td align="justify" rowspan="1" colspan="1">45</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>WashU</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" colspan="2" rowspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">cases</td><td align="justify" rowspan="1" colspan="1">23</td><td align="justify" rowspan="1" colspan="1">clinical</td><td align="justify" colspan="2" rowspan="1">Exome sequencing</td><td align="justify" rowspan="1" colspan="1">Caucasian(North American)</td><td align="justify" rowspan="1" colspan="1">57 (46&#x02013;75)</td><td align="justify" rowspan="1" colspan="1">52.17</td><td align="justify" rowspan="1" colspan="1">NA</td></tr><tr><td align="justify" rowspan="1" colspan="1">controls</td><td align="justify" rowspan="1" colspan="1">16</td><td align="justify" rowspan="1" colspan="1">clinical</td><td align="justify" colspan="2" rowspan="1">Exome sequencing</td><td align="justify" rowspan="1" colspan="1">Caucasian(North American)</td><td align="justify" rowspan="1" colspan="1">79.5 (75&#x02013;92)</td><td align="justify" rowspan="1" colspan="1">43.7</td><td align="justify" rowspan="1" colspan="1">NA</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>ADNI</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" colspan="2" rowspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">cases</td><td align="justify" rowspan="1" colspan="1">182</td><td align="justify" rowspan="1" colspan="1">clinical</td><td align="justify" colspan="2" rowspan="1">Exome sequencing</td><td align="justify" rowspan="1" colspan="1">Caucasian(North American)</td><td align="justify" rowspan="1" colspan="1">74.65 (55&#x02013;90)</td><td align="justify" rowspan="1" colspan="1">67</td><td align="justify" rowspan="1" colspan="1">56.6</td></tr><tr><td align="justify" rowspan="1" colspan="1">controls</td><td align="justify" rowspan="1" colspan="1">257</td><td align="justify" rowspan="1" colspan="1">clinical</td><td align="justify" colspan="2" rowspan="1">Exome sequencing</td><td align="justify" rowspan="1" colspan="1">Caucasian(North American)</td><td align="justify" rowspan="1" colspan="1">74.68 (60&#x02013;90)</td><td align="justify" rowspan="1" colspan="1">50.1</td><td align="justify" rowspan="1" colspan="1">27.6</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>BYU</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" colspan="2" rowspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="justify" rowspan="1" colspan="1">controls</td><td align="justify" rowspan="1" colspan="1">199</td><td align="justify" rowspan="1" colspan="1">clinical</td><td align="justify" colspan="2" rowspan="1">Genome sequencing</td><td align="justify" rowspan="1" colspan="1">Caucasian(North American)</td><td align="justify" rowspan="1" colspan="1">80.8 (75&#x02013;94.5)</td><td align="justify" rowspan="1" colspan="1">37.7</td><td align="justify" rowspan="1" colspan="1">&#x000a0;100</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>NA, not available; YRS, years.</p></fn><fn id="t001fn002"><p>*These controls have been largely used in 2 previous studies [<xref rid="pone.0150079.ref019" ref-type="bibr">19</xref>&#x02013;<xref rid="pone.0150079.ref020" ref-type="bibr">20</xref>]</p></fn></table-wrap-foot></table-wrap><p>Among the cases and controls, 42% and 51% were female, respectively. 58% and 47% of the cases and controls carried the <italic>APOE</italic> &#x003b5;4 allele, respectively. The <italic>APOE</italic> &#x003b5;4 allele was significantly associated to the disease status in the NIH and ADNI series (p-value = 0.02 and 1.19x10<sup>-9</sup>, respectively). Importantly, all the BYU controls from the Cache County Study on Memory in Aging were heterozygous for <italic>APOE</italic> &#x0025b;4 allele. However, given the fact that 1) they were elderly (mean age 80.8 years old [range: 75&#x02013;94.59]) and without any clinical sign of dementia and 2) <italic>APOE</italic> &#x0025b;4 allele is a risk but not a causative factor, we still considered them as controls and included in the study.</p><p>Written consent for participation was obtained in accordance with institutional review board standards. All samples had fully informed consent for retrieval and were authorized for ethically approved scientific investigation. The UCLH Research Ethics Committee number 10/H0716/3, BYU IRB, Cardiff REC for Wales 08/MRE09/38+5, REC Reference 04/Q2404/130, National Research Ethics Service (NRES) specifically approved this study.</p><sec id="sec003"><title>Exome sequencing</title><p>We performed whole exome sequencing on a cohort of 332 sporadic and mainly late-onset AD cases and 477 elderly controls. DNA was extracted from blood or brain both for cases and controls using standard protocols. Library preparation for next generation sequencing used DNA (between 1 &#x003bc;g and 3&#x02009;&#x003bc;g) fragmented in a Covaris E210 (Covaris Inc.). Following fragmentation, DNA was end-repaired by 5&#x02019;phosphorylation, using the Klenow polymerase. A poly-adenine tail was added to the 3&#x02019;end of the phosphorylated fragment and ligated to Illumina adapters. After purification using an AMPure DNA Purification kit (Beckman Coulter, Inc), adapter-ligated products were amplified. The DNA library was then hybridized to an exome capture library (NimbleGen SeqCap EZ Exome v2.0, Roche Nimblegen Inc. or TruSeq, Illumina Inc.) and precipitated using streptavidin-coated magnetic beads (Dynal Magnetic Beads, Invitrogen). Exome-enriched libraries were PCR-amplified, and then DNA hybridized to paired-end flow cells using a cBot (Illumina, Inc.) cluster generation system. Samples were sequenced on the Illumina HiSeq&#x02122; 2000 using 2x100 paired end reads cycles.</p></sec><sec id="sec004"><title>Whole Genome sequencing</title><p>Genome sequencing was performed in 199 elderly, clinically healthy controls, from the Cache County Study on Memory in Aging. DNA was extracted from blood using standard protocols. All samples were sequenced with the use of Illumina HiSeq technology. Alignment was performed with the use of CASAVA software and variant calling was performed with the use of SAMtools [<xref rid="pone.0150079.ref021" ref-type="bibr">21</xref>] and the Genome Analysis Toolkit GATK [<xref rid="pone.0150079.ref022" ref-type="bibr">22</xref>]. This sequencing and variant calling were performed by our collaborators at Brigham Young University.</p></sec><sec id="sec005"><title>Bioinformatic</title><p>Sequence alignment and variant calling were performed against the reference human genome (UCSC hg19). Paired end sequence reads (2x100bp paired end read cycles) were aligned using the Burrows-Wheeler aligner [<xref rid="pone.0150079.ref023" ref-type="bibr">23</xref>]. Format conversion and indexing were performed with Picard (<ext-link ext-link-type="uri" xlink:href="http://www.picard.sourceforge.net/index.shtml">www.picard.sourceforge.net/index.shtml</ext-link>). GATK was used to recalibrate base quality scores, perform local re-alignments around indels and to call and filter the variants [<xref rid="pone.0150079.ref022" ref-type="bibr">22</xref>]. VCFtools was used to annotate gene information for the remaining novel variants. We used ANNOVAR software to annotate the variants [<xref rid="pone.0150079.ref024" ref-type="bibr">24</xref>]. Variants were checked against established databases (1000 Genomes Project and dbSNP v.134). The protein coding effects of variants was predicted using SIFT, Polyphen2 and SeattleSeq Annotation (<ext-link ext-link-type="uri" xlink:href="http://gvs.gs.washington.edu/SeattleSeqAnnotation">gvs.gs.washington.edu/SeattleSeqAnnotation</ext-link>). All variants within the coding regions of 29 candidate genes (<italic>A2M</italic> [NM_000014], <italic>ACE</italic> [NM_000789], <italic>ADAM9</italic> [NM_003816], <italic>ADAM10</italic> [NM_001110], <italic>ADAM17</italic> [NM_003183], <italic>APBA1</italic> [NM_001163], <italic>APH1B</italic> [NM_031301], <italic>APLP1</italic> [NM_001024807], <italic>BACE1</italic> [NM_012104], <italic>BACE2</italic> [NM_012105], <italic>CST3</italic> [NM_000099], <italic>CTSB</italic> [NM_001908], <italic>CTSD</italic> [NM_001909], <italic>ECE1</italic> [NM_001397], <italic>ECE2</italic> [NM_014693], <italic>GPR3</italic> [NM_005281], <italic>IDE</italic> [NM_004969], <italic>LRP1</italic> [NM_002332], <italic>KLK6</italic> [NM_001012964], <italic>LRRTM3</italic> [NM_178011], <italic>LYZ</italic> [NM_000239], <italic>MEP1B</italic> [NM_005925], <italic>MME</italic> [NM_000902], <italic>MMP3</italic> [NM_002422], <italic>NCSTN</italic> [NM_015331], <italic>PLAT</italic> [NM_000930], <italic>PSENEN</italic> [NM_172341], <italic>SORL1</italic> [NM_003105], <italic>TTR</italic> [NM_000371]) have been collected and analyzed. (<bold><xref ref-type="supplementary-material" rid="pone.0150079.s001">S1 Table</xref></bold>) (Further details are provided in the supplementary materials)</p></sec><sec id="sec006"><title>Statistical Analysis</title><p>For each variant, allele frequencies were calculated in cases and controls and Fisher&#x02019;s exact test on allelic association was performed. All computations were performed in R (version x64 3.0.2, <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>). The threshold call rate for inclusion of both subjects and variants in the analysis was 95%.</p><p>In this study, we have sufficient power (&#x02265;80%) to detect common SNVs (MAF &#x0003e; 5%) with modest effect (OR = 2) through single-variant association analysis; however, we had limited power (&#x0003c;80%) to detect very rare SNVs (MAF &#x0003c; 0.1%), even those with strong effect (OR &#x0003e; 4).</p><p>A p-value of 0.05 was set as a nominal significance threshold. Based on simple Bonferroni correction for multiple testing, the thresholds for single variant and gene-based association are defined by p-value = 1.9e<sup>-4</sup> (0.05/256 coding variants) and 1.7e<sup>-3</sup> (0.05/29 genes), respectively.</p><p>For the gene-based analysis we have pooled together coding and non-coding variants with a MAF &#x02264;0.05 and studied their cumulative effect on the AD trait.</p><p>C-alpha test and SKAT are closely related, being both non-burden tests, analyzing and collapsing the effect of genetic variants of different frequency (common and rare), effect (protective, damaging and neutral) and effect size (modest, moderate, strong). SKAT can be considered an expansion of the c-alpha test because overcomes some of its limits. Indeed, SKAT 1) can be applied also to the study of continuous traits; 2) does not need any permutation; 3) applies covariates to the study. In addition, we have used a set of 5&#x02013;10 size matched genes not linked to APP-A&#x003b2; metabolism (based on a Pubmed and STRING search) as negative controls for the gene-based association analysis. Moreover, we have assessed the reliability of our results, comparing the total variant frequency of the selected genes in our study with the one reported for the European-American cohort in the Exome Variant Server (EVS)(<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>).</p></sec></sec><sec sec-type="results" id="sec007"><title>Results</title><p>The study population consisted of a total of 332 sporadic and mainly late-onset AD cases and 676 elderly controls of British and North American ancestry (<bold><xref ref-type="table" rid="pone.0150079.t001">Table 1</xref></bold>).</p><p>We do not report any pathogenic mutation in <italic>APP</italic>, <italic>PSEN1</italic> and <italic>PSEN2</italic> in our cohort. However, one of the controls was an heterozygous carrier of the protective variant <italic>APP</italic> p.A673T (MAF 7x10e<sup>-4</sup> in our cohort and MAF 5x10e<sup>-4</sup> among the European non-finnish, ExAC database, released 13 January 2015).</p><p>We performed a single-variant and a single-gene association analysis in a pre-defined set of genes involved in APP processing (<italic>ADAM9</italic>, <italic>ADAM10</italic>, <italic>ADAM17</italic>, <italic>MEP1B</italic>, <italic>BACE1</italic>, <italic>BACE2</italic>, <italic>NCSTN</italic>, <italic>PSENEN</italic>, <italic>APH1B</italic>, <italic>APLP1</italic>, <italic>APBA1)</italic>, A&#x003b2; metabolism and catabolism (<italic>LRRTM3</italic>, <italic>LRP1</italic>, <italic>TTR</italic>, <italic>GPR3</italic>, <italic>SORL1</italic>, <italic>ECE1</italic>, <italic>ECE2</italic>, <italic>IDE</italic>, <italic>CST3</italic>, <italic>CTSB</italic>, <italic>CTSD</italic>, <italic>LYZ</italic>, <italic>MME</italic>, <italic>ACE</italic>, <italic>MMP3</italic>, <italic>A2M</italic>, <italic>PLAT</italic>, KLK6), including 68 Megabase pairs (Mbs) of coding sequence.</p><p>A total of 960 single nucleotide variants (SNVs) has been identified. Among these, 256 (26.6%) were nonsynonymous, 194 (20.20%) were synonymous, 97 (10.1%) were intronic and 413 (43%) UTR variants. Among the missense variants, 192 (75%) were very rare (MAF&#x0003c;1%), 16 (6.25%) were low frequency (1%&#x0003c;MAF&#x0003c;5%) and 12(4.68%) were common (MAF&#x0003e;5%). In addition, we report 36 novel coding variants. Variant minor allele frequency and novel variants were based on ExAC database, released 13 January 2015, or dbSNP 137(<bold><xref ref-type="supplementary-material" rid="pone.0150079.s002">S2 Table</xref></bold>). The overall variant frequency in our cohort was in line with the variant frequency reported in the American-European cohort in the Exome Variant server database (<bold><xref ref-type="supplementary-material" rid="pone.0150079.s003">S3 Table</xref></bold>).</p><p>Moreover, 120 missense variants (46.8%) were described as damaging variants by at least 2 out of 3 <italic>in silico</italic> prediction softwares (SIFT, Polyphen and Mutation Taster). Importantly, genes involved in A&#x003b2; degradation and clearance harbor the highest relative frequency of rare coding and damaging variants (mean = 4.73 rare coding variants/Kbp of coding sequence and 3.16 damaging coding variants/Kbp of coding sequence, respectively). By contrast, genes taking part in APP processing and A&#x003b2; production, present the lowest relative frequency of rare coding and damaging variants (mean = 3.59 rare coding variants/Kbp of coding sequence and 1.5 damaging coding variants/Kbp of coding sequence, respectively), suggesting a higher degree of conservation of this last cluster of genes (<bold><xref ref-type="supplementary-material" rid="pone.0150079.s004">S4</xref> and <xref ref-type="supplementary-material" rid="pone.0150079.s005">S5</xref> Tables</bold>).</p><sec id="sec008"><title>Single coding variant association test</title><p>We identified 3 nominally significant variants, clustering in genes involved in A&#x003b2; catabolism (<italic>TTR</italic> [p.T139M], <italic>ACE</italic> [p.T916M]) and APP cleavage (<italic>APH1B</italic> [p.T27I]). Overall, the main hits (variants with the lowest p-values) mainly cluster to genes predominantly involved in A&#x003b2; degradation and clearance (6 out of 8 genes [75%]), with <italic>ACE</italic>, <italic>SORL1</italic> and <italic>LRP1</italic> harboring multiple variants, compared to APP processing (2 out of 8 genes [25%]). Moreover, most of these top genes are highly expressed in the brain (<ext-link ext-link-type="uri" xlink:href="http://biogps.org/">http://biogps.org/</ext-link>) and harbor very rare coding variants (0.009%&#x0003c;MAF&#x0003c;1.4%) with moderate to strong effect size (1.84&#x0003c;OR&#x0003c;Inf). (<bold><xref ref-type="table" rid="pone.0150079.t002">Table 2</xref></bold>).</p><table-wrap id="pone.0150079.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0150079.t002</object-id><label>Table 2</label><caption><title>Most significant variants.</title></caption><alternatives><graphic id="pone.0150079.t002g" xlink:href="pone.0150079.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">GENE</th><th align="justify" rowspan="1" colspan="1">POSITION</th><th align="justify" rowspan="1" colspan="1">RS ID</th><th align="justify" rowspan="1" colspan="1">nucleotide change</th><th align="justify" rowspan="1" colspan="1">Aa change</th><th align="justify" rowspan="1" colspan="1">CARRIER AD (%)</th><th align="justify" rowspan="1" colspan="1">CARRIER. CTRLS (%)</th><th align="justify" rowspan="1" colspan="1">SIFT</th><th align="justify" rowspan="1" colspan="1">POLYPHEN</th><th align="justify" rowspan="1" colspan="1">MAF cases-ctrls</th><th align="justify" rowspan="1" colspan="1">ExAC</th><th align="justify" rowspan="1" colspan="1">PVAL</th><th align="justify" rowspan="1" colspan="1">Corrected p-value</th><th align="justify" rowspan="1" colspan="1">OR</th><th align="justify" rowspan="1" colspan="1">OR 95% CI</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><italic>TTR</italic></td><td align="justify" rowspan="1" colspan="1">chr18:29178610</td><td align="justify" rowspan="1" colspan="1">rs28933981</td><td align="justify" rowspan="1" colspan="1">c.C416T</td><td align="justify" rowspan="1" colspan="1">p.T139M</td><td align="justify" rowspan="1" colspan="1">6/332 (1.8)</td><td align="justify" rowspan="1" colspan="1">2/676 (0.29)</td><td align="justify" rowspan="1" colspan="1">deleterious</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0.009&#x02013;0.0014</td><td align="justify" rowspan="1" colspan="1">0.001475</td><td align="justify" rowspan="1" colspan="1">0.018</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">6.19</td><td align="justify" rowspan="1" colspan="1">1.099&#x02013;63.091</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>ACE</italic></td><td align="justify" rowspan="1" colspan="1">chr17:61568577</td><td align="justify" rowspan="1" colspan="1">rs3730043</td><td align="justify" rowspan="1" colspan="1">c.C2747T</td><td align="justify" rowspan="1" colspan="1">p.T916M</td><td align="justify" rowspan="1" colspan="1">10/332 (3)</td><td align="justify" rowspan="1" colspan="1">8/676 (1.18)</td><td align="justify" rowspan="1" colspan="1">deleterious</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0.015&#x02013;0.006</td><td align="justify" rowspan="1" colspan="1">0.004348</td><td align="justify" rowspan="1" colspan="1">0.0456</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">2.59</td><td align="justify" rowspan="1" colspan="1">0.910&#x02013;7.631</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>APH1B</italic></td><td align="justify" rowspan="1" colspan="1">chr15:63569902</td><td align="justify" rowspan="1" colspan="1">rs117618017</td><td align="justify" rowspan="1" colspan="1">c.C80T</td><td align="justify" rowspan="1" colspan="1">p.T27I</td><td align="justify" rowspan="1" colspan="1">53/332 (15.9)</td><td align="justify" rowspan="1" colspan="1">144/676 (21.3)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">benign</td><td align="justify" rowspan="1" colspan="1">0.08&#x02013;0.106</td><td align="justify" rowspan="1" colspan="1">0.09078</td><td align="justify" rowspan="1" colspan="1">0.051</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">0.702</td><td align="justify" rowspan="1" colspan="1">0.486&#x02013;1.003</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>SORL1</italic></td><td align="justify" rowspan="1" colspan="1">chr11:121367627</td><td align="justify" rowspan="1" colspan="1">rs117260922</td><td align="justify" rowspan="1" colspan="1">c.G808A</td><td align="justify" rowspan="1" colspan="1">p.E270K</td><td align="justify" rowspan="1" colspan="1">16/332 (4.8)</td><td align="justify" rowspan="1" colspan="1">18/676 (2.6)</td><td align="justify" rowspan="1" colspan="1">deleterious</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0.024&#x02013;0.013</td><td align="justify" rowspan="1" colspan="1">0.01468</td><td align="justify" rowspan="1" colspan="1">0.0936</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1.849</td><td align="justify" rowspan="1" colspan="1">0.869&#x02013;3.90</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>SORL1</italic></td><td align="justify" rowspan="1" colspan="1">chr11:121495816</td><td align="justify" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org/Homo_sapiens/Variation/Summary?db=core;g=ENSG00000137642;r=11:121322912-121504402;t=ENST00000260197;v=rs140327834;vf=31828109;source=dbSNP">rs140327834</ext-link></td><td align="justify" rowspan="1" colspan="1">c.A6194T</td><td align="justify" rowspan="1" colspan="1">p.D2065V</td><td align="justify" rowspan="1" colspan="1">0/332 (0)</td><td align="justify" rowspan="1" colspan="1">7/676 (1.03)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0&#x02013;0.005</td><td align="justify" rowspan="1" colspan="1">0.002823</td><td align="justify" rowspan="1" colspan="1">0.102</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0&#x02013;1.407</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>CTSB</italic></td><td align="justify" rowspan="1" colspan="1">chr8:11704617</td><td align="justify" rowspan="1" colspan="1">rs114308907</td><td align="justify" rowspan="1" colspan="1">c.A737C</td><td align="justify" rowspan="1" colspan="1">p.N246T</td><td align="justify" rowspan="1" colspan="1">3/332 (0.9)</td><td align="justify" rowspan="1" colspan="1">1/676 (0.14)</td><td align="justify" rowspan="1" colspan="1">deleterious</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0.004&#x02013;0.0007</td><td align="justify" rowspan="1" colspan="1">0.001936</td><td align="justify" rowspan="1" colspan="1">0.107</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">6.143</td><td align="justify" rowspan="1" colspan="1">0.491&#x02013;322.997</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>LRP1</italic></td><td align="justify" rowspan="1" colspan="1">chr12:57606021</td><td align="justify" rowspan="1" colspan="1">rs142605462</td><td align="justify" rowspan="1" colspan="1">c.G13471C</td><td align="justify" rowspan="1" colspan="1">p.D4491H</td><td align="justify" rowspan="1" colspan="1">3/332 (0.9)</td><td align="justify" rowspan="1" colspan="1">1/676 (0.14)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0.004&#x02013;0.0007</td><td align="justify" rowspan="1" colspan="1">0.0005242</td><td align="justify" rowspan="1" colspan="1">0.107</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">6.143</td><td align="justify" rowspan="1" colspan="1">0.491&#x02013;322.997</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>MMP3</italic></td><td align="justify" rowspan="1" colspan="1">chr11:102711201</td><td align="justify" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org/Homo_sapiens/Variation/Summary?db=core;g=ENSG00000149968;r=11:102706532-102714534;t=ENST00000299855;v=rs148047905;vf=38234085;source=dbSNP">rs148047905</ext-link></td><td align="justify" rowspan="1" colspan="1">c.G749A</td><td align="justify" rowspan="1" colspan="1">p.R250H</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">benign</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">0.0004121</td><td align="justify" rowspan="1" colspan="1">0.1083</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>NCSTN</italic></td><td align="justify" rowspan="1" colspan="1">chr1:160321594</td><td align="justify" rowspan="1" colspan="1">NA</td><td align="justify" rowspan="1" colspan="1">c.G842A</td><td align="justify" rowspan="1" colspan="1">p.R281Q</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">benign</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">0.00009889</td><td align="justify" rowspan="1" colspan="1">0.108</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>SORL1</italic></td><td align="justify" rowspan="1" colspan="1">chr11:121323072</td><td align="justify" rowspan="1" colspan="1">rs147575757</td><td align="justify" rowspan="1" colspan="1">c.G32C</td><td align="justify" rowspan="1" colspan="1">p.R11P</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">deleterious</td><td align="justify" rowspan="1" colspan="1">benign</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">0.0002606</td><td align="justify" rowspan="1" colspan="1">0.108</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>ACE</italic></td><td align="justify" rowspan="1" colspan="1">chr17:61564428</td><td align="justify" rowspan="1" colspan="1">rs148995315</td><td align="justify" rowspan="1" colspan="1">c.G2299A</td><td align="justify" rowspan="1" colspan="1">p.E767K</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">deleterious</td><td align="justify" rowspan="1" colspan="1">possibly damaging</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">0.0003083</td><td align="justify" rowspan="1" colspan="1">0.108</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>LRP1</italic></td><td align="justify" rowspan="1" colspan="1">chr12:57522754</td><td align="justify" rowspan="1" colspan="1">NA</td><td align="justify" rowspan="1" colspan="1">c.A7C</td><td align="justify" rowspan="1" colspan="1">p.T3P</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">benign</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">NA</td><td align="justify" rowspan="1" colspan="1">0.108</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>LRP1</italic></td><td align="justify" rowspan="1" colspan="1">chr12:57589676</td><td align="justify" rowspan="1" colspan="1">rs143285614</td><td align="justify" rowspan="1" colspan="1">c.G8591A</td><td align="justify" rowspan="1" colspan="1">p.R2864H</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">benign</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">0.0001904</td><td align="justify" rowspan="1" colspan="1">0.108</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr><tr><td align="justify" rowspan="1" colspan="1"><italic>LRP1</italic></td><td align="justify" rowspan="1" colspan="1">chr12:57587773</td><td align="justify" rowspan="1" colspan="1">rs149099223</td><td align="justify" rowspan="1" colspan="1">c.C7896A</td><td align="justify" rowspan="1" colspan="1">p.D2632E</td><td align="justify" rowspan="1" colspan="1">2/332 (0.6)</td><td align="justify" rowspan="1" colspan="1">0/676 (0)</td><td align="justify" rowspan="1" colspan="1">tolerated</td><td align="justify" rowspan="1" colspan="1">probably damaging</td><td align="justify" rowspan="1" colspan="1">0.003&#x02013;0</td><td align="justify" rowspan="1" colspan="1">0.0005081</td><td align="justify" rowspan="1" colspan="1">0.1083</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Inf</td><td align="justify" rowspan="1" colspan="1">0.382- Inf</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Position is in hg19/GRCh37. MA, minor allele; CTRLS, controls; MAF, minor allele frequency; OR, odds ratio; inf, infinity; CI, confidence interval. Corrected p-value, p-value after Bonferroni correction (p-value*256 [number of variants considered in the single-variant association test])</p></fn></table-wrap-foot></table-wrap><p>However, none of the coding variants detected in the studied genes reached the statistical significance, based on a corrected p-value (p-value &#x0003c;1.9e<sup>-4</sup>), in the single-variant association test.</p><p>For all these main variants, with the <italic>APH1B</italic> (p.T27I) and <italic>SORL</italic>1 (p.D2065V) exceptions, the minor allele was substantially more frequent in cases compared to controls, suggesting a possible role as a risk factor for AD. The study possessed relatively low power to detect any significant association between cases and controls for low frequency and rare variants. Nevertheless, we analyzed these variants because we could not preclude the possibility that high effect risk alleles were present.</p></sec><sec id="sec009"><title>Gene-based association test</title><p>In addition to single-marker analysis, we performed gene-wide analysis to combine the joint signal from multiple coding and non-coding variants with a MAF&#x02264; 0.05 within a gene and to provide greater statistical power than that for single-marker tests. All the variants (nonsynonymous, synonymous, UTRs) located within the studied genes and their exon-intron flanking regions were collapsed together and their joint effect has been studied and compared with 5 to 10 size and variant matched gene controls (<bold><xref ref-type="supplementary-material" rid="pone.0150079.s006">S6A and S6B Table</xref></bold>). Genes involved in A&#x003b2; degradation and clearance were enriched for the lowest p-values. The combined effect of variants in <italic>ECE1</italic>, <italic>LYZ</italic> and in <italic>TTR</italic> reached the nominal significance in the c-alpha and SKAT tests, respectively (1.7e<sup>-3</sup> &#x0003c;p-value &#x0003c;0.05) (<bold>Tables <xref ref-type="table" rid="pone.0150079.t003">3</xref> and <xref ref-type="table" rid="pone.0150079.t004">4</xref></bold>). There was a partial overlap between genes identified in the single-marker analysis and those with SKAT and c-alpha tests. Importantly, <italic>TTR</italic> was the main finding both in the SKAT and single-marker association analysis. Therefore, suggesting <italic>TTR</italic> as a promising potential candidate risk gene for AD.</p><table-wrap id="pone.0150079.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0150079.t003</object-id><label>Table 3</label><caption><title>C-ALPHA TEST.</title></caption><alternatives><graphic id="pone.0150079.t003g" xlink:href="pone.0150079.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">TRANSCRIPT ID</th><th align="justify" rowspan="1" colspan="1">POSITION</th><th align="justify" rowspan="1" colspan="1">GENE</th><th align="justify" rowspan="1" colspan="1">N.VARIANTS</th><th align="justify" rowspan="1" colspan="1">TEST</th><th align="justify" rowspan="1" colspan="1">P-VALUE</th><th align="justify" rowspan="1" colspan="1">CORRECTED P-VALUE</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">NM_001397</td><td align="justify" rowspan="1" colspan="1">chr1:21543823..21671981</td><td align="justify" rowspan="1" colspan="1"><italic>ECE1</italic></td><td align="justify" rowspan="1" colspan="1">51</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.00576606</td><td align="justify" rowspan="1" colspan="1">0.1653</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000239</td><td align="justify" rowspan="1" colspan="1">chr12:69742188..69747889</td><td align="justify" rowspan="1" colspan="1"><italic>LYZ</italic></td><td align="justify" rowspan="1" colspan="1">5</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.0322581</td><td align="justify" rowspan="1" colspan="1">0.928</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001908</td><td align="justify" rowspan="1" colspan="1">chr8:11700101..11725587</td><td align="justify" rowspan="1" colspan="1"><italic>CTSB</italic></td><td align="justify" rowspan="1" colspan="1">75</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.0706522</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000371</td><td align="justify" rowspan="1" colspan="1">chr18:29171879..29178899</td><td align="justify" rowspan="1" colspan="1"><italic>TTR</italic></td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.142857</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_003183</td><td align="justify" rowspan="1" colspan="1">chr2:9629731..9695906</td><td align="justify" rowspan="1" colspan="1"><italic>ADAM17</italic></td><td align="justify" rowspan="1" colspan="1">18</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.16</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_014693</td><td align="justify" rowspan="1" colspan="1">chr3:183967457..184010734</td><td align="justify" rowspan="1" colspan="1"><italic>ECE2</italic></td><td align="justify" rowspan="1" colspan="1">32</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.22</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000789</td><td align="justify" rowspan="1" colspan="1">chr17:61554500..61574779</td><td align="justify" rowspan="1" colspan="1"><italic>ACE</italic></td><td align="justify" rowspan="1" colspan="1">45</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.193548</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_003816</td><td align="justify" rowspan="1" colspan="1">chr8:38854521..38962660</td><td align="justify" rowspan="1" colspan="1"><italic>ADAM9</italic></td><td align="justify" rowspan="1" colspan="1">23</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.196429</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001110</td><td align="justify" rowspan="1" colspan="1">chr15:58888656..59042155</td><td align="justify" rowspan="1" colspan="1"><italic>ADAM10</italic></td><td align="justify" rowspan="1" colspan="1">26</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.275</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_031301</td><td align="justify" rowspan="1" colspan="1">chr15:63569800..63601264</td><td align="justify" rowspan="1" colspan="1"><italic>APH1B</italic></td><td align="justify" rowspan="1" colspan="1">39</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.277778</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000014</td><td align="justify" rowspan="1" colspan="1">chr12:9220607..9268549</td><td align="justify" rowspan="1" colspan="1"><italic>A2M</italic></td><td align="justify" rowspan="1" colspan="1">26</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.277778</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_012105</td><td align="justify" rowspan="1" colspan="1">chr21:42539814..42648229</td><td align="justify" rowspan="1" colspan="1"><italic>BACE2</italic></td><td align="justify" rowspan="1" colspan="1">88</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.285714</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_002332</td><td align="justify" rowspan="1" colspan="1">chr12:57522754..57607023</td><td align="justify" rowspan="1" colspan="1"><italic>LRP1</italic></td><td align="justify" rowspan="1" colspan="1">111</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.322581</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_015331</td><td align="justify" rowspan="1" colspan="1">chr1:160313330..160328428</td><td align="justify" rowspan="1" colspan="1"><italic>NCSTN</italic></td><td align="justify" rowspan="1" colspan="1">21</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.36</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001012964</td><td align="justify" rowspan="1" colspan="1">chr19:51462012..51471329</td><td align="justify" rowspan="1" colspan="1"><italic>KLK6</italic></td><td align="justify" rowspan="1" colspan="1">11</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.444444</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000902</td><td align="justify" rowspan="1" colspan="1">chr3:154797478..154901245</td><td align="justify" rowspan="1" colspan="1"><italic>MME</italic></td><td align="justify" rowspan="1" colspan="1">40</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.6</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_012104</td><td align="justify" rowspan="1" colspan="1">chr11:117156543..117186818</td><td align="justify" rowspan="1" colspan="1"><italic>BACE1</italic></td><td align="justify" rowspan="1" colspan="1">39</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.714286</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000099</td><td align="justify" rowspan="1" colspan="1">chr20:23614297..23618571</td><td align="justify" rowspan="1" colspan="1"><italic>CST3</italic></td><td align="justify" rowspan="1" colspan="1">12</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.714286</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_002422</td><td align="justify" rowspan="1" colspan="1">chr11:102706685..102714317</td><td align="justify" rowspan="1" colspan="1"><italic>MMP3</italic></td><td align="justify" rowspan="1" colspan="1">16</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.714286</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001163</td><td align="justify" rowspan="1" colspan="1">chr9:72042470..72287163</td><td align="justify" rowspan="1" colspan="1"><italic>APBA1</italic></td><td align="justify" rowspan="1" colspan="1">41</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.833333</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_178011</td><td align="justify" rowspan="1" colspan="1">chr10:68685929..68860827</td><td align="justify" rowspan="1" colspan="1"><italic>LRRTM3</italic></td><td align="justify" rowspan="1" colspan="1">29</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">0.833333</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_172341</td><td align="justify" rowspan="1" colspan="1">chr19:36237681..36237803</td><td align="justify" rowspan="1" colspan="1"><italic>PSENEN</italic></td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_005925</td><td align="justify" rowspan="1" colspan="1">chr18:29772759..29800324</td><td align="justify" rowspan="1" colspan="1"><italic>MEP1B</italic></td><td align="justify" rowspan="1" colspan="1">19</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001024807</td><td align="justify" rowspan="1" colspan="1">chr19:36360709..36370689</td><td align="justify" rowspan="1" colspan="1"><italic>APLP1</italic></td><td align="justify" rowspan="1" colspan="1">22</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_005281</td><td align="justify" rowspan="1" colspan="1">chr1:27720353..27722269</td><td align="justify" rowspan="1" colspan="1"><italic>GPR3</italic></td><td align="justify" rowspan="1" colspan="1">17</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_003105</td><td align="justify" rowspan="1" colspan="1">chr11:121323007..121504463</td><td align="justify" rowspan="1" colspan="1"><italic>SORL1</italic></td><td align="justify" rowspan="1" colspan="1">88</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_004969</td><td align="justify" rowspan="1" colspan="1">chr10:94211444..94333827</td><td align="justify" rowspan="1" colspan="1"><italic>IDE</italic></td><td align="justify" rowspan="1" colspan="1">27</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001909</td><td align="justify" rowspan="1" colspan="1">chr11:1774022..1782657</td><td align="justify" rowspan="1" colspan="1"><italic>CTSD</italic></td><td align="justify" rowspan="1" colspan="1">20</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000930</td><td align="justify" rowspan="1" colspan="1">chr8:42032237..42065098</td><td align="justify" rowspan="1" colspan="1"><italic>PLAT</italic></td><td align="justify" rowspan="1" colspan="1">24</td><td align="justify" rowspan="1" colspan="1">CALPHA</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>N. VARIANTS, number of variants. Position is in hg19/GRCh37. Statistical significance p-value &#x0003c; 1.7e<sup>-3</sup>. Corrected p-value, p-value after Bonferroni correction (p-value*29 [number of genes considered in the single-variant association test])</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0150079.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0150079.t004</object-id><label>Table 4</label><caption><title>SKAT TEST.</title></caption><alternatives><graphic id="pone.0150079.t004g" xlink:href="pone.0150079.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">TRANSCRIPT ID</th><th align="justify" rowspan="1" colspan="1">POSITION</th><th align="justify" rowspan="1" colspan="1">GENE</th><th align="justify" rowspan="1" colspan="1">N.VARIANTS</th><th align="justify" rowspan="1" colspan="1">TEST</th><th align="justify" rowspan="1" colspan="1">P-VALUE</th><th align="justify" rowspan="1" colspan="1">CORRECTED P-VALUE</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">NM_000371</td><td align="justify" rowspan="1" colspan="1">chr18:29171879..29178899</td><td align="justify" rowspan="1" colspan="1"><italic>TTR</italic></td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.0234248</td><td align="justify" rowspan="1" colspan="1">0.667</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000902</td><td align="justify" rowspan="1" colspan="1">chr3:154797478..154901245</td><td align="justify" rowspan="1" colspan="1"><italic>MME</italic></td><td align="justify" rowspan="1" colspan="1">40</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.0558425</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_003816</td><td align="justify" rowspan="1" colspan="1">chr8:38854521..38962660</td><td align="justify" rowspan="1" colspan="1"><italic>ADAM9</italic></td><td align="justify" rowspan="1" colspan="1">23</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.0986587</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_003183</td><td align="justify" rowspan="1" colspan="1">chr2:9629731..9695906</td><td align="justify" rowspan="1" colspan="1"><italic>ADAM17</italic></td><td align="justify" rowspan="1" colspan="1">18</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.132024</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_002422</td><td align="justify" rowspan="1" colspan="1">chr11:102706685..102714317</td><td align="justify" rowspan="1" colspan="1"><italic>MMP3</italic></td><td align="justify" rowspan="1" colspan="1">16</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.171193</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_003105</td><td align="justify" rowspan="1" colspan="1">chr11:121323007..121504463</td><td align="justify" rowspan="1" colspan="1"><italic>SORL1</italic></td><td align="justify" rowspan="1" colspan="1">88</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.230435</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001908</td><td align="justify" rowspan="1" colspan="1">chr8:11700101..11725587</td><td align="justify" rowspan="1" colspan="1"><italic>CTSB</italic></td><td align="justify" rowspan="1" colspan="1">75</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.231384</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_015331</td><td align="justify" rowspan="1" colspan="1">chr1:160313330..160328428</td><td align="justify" rowspan="1" colspan="1"><italic>NCSTN</italic></td><td align="justify" rowspan="1" colspan="1">21</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.273587</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000789</td><td align="justify" rowspan="1" colspan="1">chr17:61554500..61574779</td><td align="justify" rowspan="1" colspan="1"><italic>ACE</italic></td><td align="justify" rowspan="1" colspan="1">45</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.311289</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_012104</td><td align="justify" rowspan="1" colspan="1">chr11:117156543..117186818</td><td align="justify" rowspan="1" colspan="1"><italic>BACE1</italic></td><td align="justify" rowspan="1" colspan="1">39</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.350782</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_005925</td><td align="justify" rowspan="1" colspan="1">chr18:29772759..29800324</td><td align="justify" rowspan="1" colspan="1"><italic>MEP1B</italic></td><td align="justify" rowspan="1" colspan="1">19</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.404511</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_031301</td><td align="justify" rowspan="1" colspan="1">chr15:63569800..63601264</td><td align="justify" rowspan="1" colspan="1"><italic>APH1B</italic></td><td align="justify" rowspan="1" colspan="1">39</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.415623</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001110</td><td align="justify" rowspan="1" colspan="1">chr15:58888656..59042155</td><td align="justify" rowspan="1" colspan="1"><italic>ADAM10</italic></td><td align="justify" rowspan="1" colspan="1">26</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.416865</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000239</td><td align="justify" rowspan="1" colspan="1">chr12:69742188..69747889</td><td align="justify" rowspan="1" colspan="1"><italic>LYZ</italic></td><td align="justify" rowspan="1" colspan="1">5</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.454856</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_012105</td><td align="justify" rowspan="1" colspan="1">chr21:42539814..42648229</td><td align="justify" rowspan="1" colspan="1"><italic>BACE2</italic></td><td align="justify" rowspan="1" colspan="1">88</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.465396</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000099</td><td align="justify" rowspan="1" colspan="1">chr20:23614297..23618571</td><td align="justify" rowspan="1" colspan="1"><italic>CST3</italic></td><td align="justify" rowspan="1" colspan="1">12</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.485137</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001012964</td><td align="justify" rowspan="1" colspan="1">chr19:51462012..51471329</td><td align="justify" rowspan="1" colspan="1"><italic>KLK6</italic></td><td align="justify" rowspan="1" colspan="1">11</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.586652</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000014</td><td align="justify" rowspan="1" colspan="1">chr12:9220607..9268549</td><td align="justify" rowspan="1" colspan="1"><italic>A2M</italic></td><td align="justify" rowspan="1" colspan="1">26</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.600323</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_172341</td><td align="justify" rowspan="1" colspan="1">chr19:36237681..36237803</td><td align="justify" rowspan="1" colspan="1"><italic>PSENEN</italic></td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.61164</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_014693</td><td align="justify" rowspan="1" colspan="1">chr3:183967457..184010734</td><td align="justify" rowspan="1" colspan="1"><italic>ECE2</italic></td><td align="justify" rowspan="1" colspan="1">32</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.808793</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_002332</td><td align="justify" rowspan="1" colspan="1">chr12:57522754..57607023</td><td align="justify" rowspan="1" colspan="1"><italic>LRP1</italic></td><td align="justify" rowspan="1" colspan="1">111</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.813088</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001163</td><td align="justify" rowspan="1" colspan="1">chr9:72042470..72287163</td><td align="justify" rowspan="1" colspan="1"><italic>APBA1</italic></td><td align="justify" rowspan="1" colspan="1">41</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.815816</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001024807</td><td align="justify" rowspan="1" colspan="1">chr19:36360709..36370689</td><td align="justify" rowspan="1" colspan="1"><italic>APLP1</italic></td><td align="justify" rowspan="1" colspan="1">22</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.848962</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_004969</td><td align="justify" rowspan="1" colspan="1">chr10:94211444..94333827</td><td align="justify" rowspan="1" colspan="1"><italic>IDE</italic></td><td align="justify" rowspan="1" colspan="1">27</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.868194</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001397</td><td align="justify" rowspan="1" colspan="1">chr1:21543823..21671981</td><td align="justify" rowspan="1" colspan="1"><italic>ECE1</italic></td><td align="justify" rowspan="1" colspan="1">51</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.894799</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_178011</td><td align="justify" rowspan="1" colspan="1">chr10:68685929..68860827</td><td align="justify" rowspan="1" colspan="1"><italic>LRRTM3</italic></td><td align="justify" rowspan="1" colspan="1">29</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.890455</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_001909</td><td align="justify" rowspan="1" colspan="1">chr11:1774022..1782657</td><td align="justify" rowspan="1" colspan="1"><italic>CTSD</italic></td><td align="justify" rowspan="1" colspan="1">20</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.899719</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_000930</td><td align="justify" rowspan="1" colspan="1">chr8:42032237..42065098</td><td align="justify" rowspan="1" colspan="1"><italic>PLAT</italic></td><td align="justify" rowspan="1" colspan="1">24</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.906314</td><td align="justify" rowspan="1" colspan="1">1</td></tr><tr><td align="justify" rowspan="1" colspan="1">NM_005281</td><td align="justify" rowspan="1" colspan="1">chr1:27720353..27722269</td><td align="justify" rowspan="1" colspan="1"><italic>GPR3</italic></td><td align="justify" rowspan="1" colspan="1">17</td><td align="justify" rowspan="1" colspan="1">SKAT</td><td align="justify" rowspan="1" colspan="1">0.975572</td><td align="justify" rowspan="1" colspan="1">1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>N. VARIANTS, number of variants. Position is in hg19/GRCh37. Statistical significance p-value &#x0003c; 1.7e<sup>-3</sup>. Corrected p-value, p-value after Bonferroni correction (p-value*29 [number of genes considered in the single-variant association test])</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec010"><title>Discussion</title><p>The Amyloid cascade hypothesis is the main accepted hypothesis underlying AD pathology. Several genes within the APP-A&#x003b2; metabolism pathway have been reported as potential candidate genes for AD. However, coding variability among these has not been extensively investigated. The vast majority of reported studies are based on candidate gene approaches using array-based SNP genotyping and are focused mainly on genes involved in A&#x003b2; catabolism (<ext-link ext-link-type="uri" xlink:href="http://www.alzgene.org/">http://www.alzgene.org/</ext-link>). Thus, leaving low frequency and rare coding variants and genes involved in A&#x003b2; production largely unexplored.</p><p>GWASs and chip-based candidate gene approaches have shown that common and generally non-coding variability within these genes does not play a critical role for AD development. The only exceptions to this general rule are represented by <italic>SORL1</italic> and <italic>ABCA7</italic>, which have been reported associated with late-onset apparently sporadic and familial AD both with GWASs, candidate gene approaches and exome sequencing [<xref rid="pone.0150079.ref025" ref-type="bibr">25</xref>&#x02013;<xref rid="pone.0150079.ref028" ref-type="bibr">28</xref>].</p><p>In this study, we report a screening of genes known to be involved in the APP-A&#x003b2; metabolism (APP processing, A&#x003b2; production, degradation and clearance). We applied single-marker and gene-based association analyses, to investigate the independent and joint effect of coding variability within these genes in a cohort composed of 332 apparently sporadic and mainly late-onset AD cases and 676 elderly controls from North America and the UK.</p><p>In our cohort, genes involved in A&#x003b2; degradation and clearance harbor the highest relative frequency of rare and predicted damaging variants (mean = 4.73 rare coding variants/Kbp of coding sequence and 3.16 damaging coding variants/Kbp of coding sequence, respectively). Conversely, genes encoding for proteins regulating A&#x003b2; production presented the lowest relative frequency of coding and likely damaging variability (mean = 3.59 rare coding variants/Kbp of coding sequence and 1.5 damaging coding variants/Kbp of coding sequence, respectively) (<bold><xref ref-type="supplementary-material" rid="pone.0150079.s004">S4</xref> and <xref ref-type="supplementary-material" rid="pone.0150079.s005">S5</xref> Tables</bold>), suggesting a higher degree of conservation.</p><p>In the single-variant association analysis, the main hits were very rare coding variants (MAF 0.009%&#x0003c; MAF&#x0003c;1.4%) with strong effect sizes (1.84&#x0003c;OR&#x0003c;Inf) mapping to genes involved in A&#x003b2; extracellular degradation (<italic>ACE</italic>, <italic>TTR</italic>, <italic>CTSB</italic>, <italic>MMP3</italic>), APP trafficking and recycling (<italic>SORL1</italic>), and clearance (<italic>LRP1</italic>). Among the main single-marker hits only 2 genes (<italic>APH1B</italic>, <italic>NCSTN)</italic> were component of the &#x003b3; secretase complex and therefore pivotal for APP processing. Our study was underpowered for the detection of rare and low frequency variants and these variants were nominally significant after Bonferroni correction (1.9e<sup>-4</sup>&#x0003c;p-value &#x0003c;0.05). Importantly, in our cohort, <italic>TREM2</italic> p.R47H, the second most common risk factor for sporadic AD, has been detected in 6 cases (1.8%) and 4 controls (0.59%) and, given our small sample size, with a MAF = 0.2%, was not significantly associated to AD (p-value = 0.09). Therefore, we suggest that the main variants detected in our study may be functional and warrant a follow up in an extended sample size.</p><p>Transthyretin (TTR) is a 55-kDa protein, particularly abundant in the CSF and human plasma, where it transports thyroxin from the peripheral blood circulation to the brain. TTR has been already reported linked to AD dementia. Particularly, it has been hypothesized that TTR may act as a scaffold protein, binding to amyloid and preventing its deposition and aggregation in plaques [<xref rid="pone.0150079.ref029" ref-type="bibr">29</xref>]. Moreover, TTR is a well established biomarker for AD: 1) a decrese in the CSF and serum TTR levels has been associated to an increased AD severity and faster rate of disease progression and 2) 5 SNPs and different <italic>TTR</italic> haplotypes have been related to hippocampal atrophy [<xref rid="pone.0150079.ref030" ref-type="bibr">30</xref>]. By contrast, TTR overexpression decreases A&#x003b2; deposition, protects against A&#x003b2; plaques formation and improves the cognitive function in different AD mouse model strains [<xref rid="pone.0150079.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pone.0150079.ref032" ref-type="bibr">32</xref>]. Finally, TTR, likewise other well conserved secreted proteins critically involved in dementia (PRP and PGRN), has no homologous proteins (<ext-link ext-link-type="uri" xlink:href="http://string-db.org/">http://string-db.org/</ext-link>), therefore implying that even subtle changes to its epitopes and/or domains may be functionally relevant and phenotypically manifest. In line with this hypothesis, <italic>TTR</italic> is the main hit both in the single-variant analysis and, with only 6 variants detected (4 coding and 2 3&#x000b4; UTR variants), in the gene-based analysis (SKAT). Thus, suggesting that either the joint effect of the coding and non-coding variability at the <italic>TTR</italic> locus is likely to be functional or that the signal is driven by <italic>TTR</italic> p.T139M, that has a very strong effect size (OR = 6.19, 95% CI = 1.099&#x02013;63.091).</p><p>The second strongest signal in the single variant analysis maps to <italic>ACE</italic> (p.T916M), encoding angiotensin I converting enzyme 1 (ACE1), a zinc metalloprotease, which regulates blood pressure. Multiple lines of evidence have shown that ACE1 may ameliorate the cognitive decline either regulating the cerebral blood flow and/or converting A&#x003b2;<sub>42</sub> to A&#x003b2;<sub>40</sub>, a more soluble isoform and its activity is increased in AD brain, in proportion to the parenchymal A&#x003b2; load [<xref rid="pone.0150079.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0150079.ref035" ref-type="bibr">35</xref>].</p><p><italic>SORL1</italic> encodes for Sortilin related receptor (SORLA, also known as LR11), which binds to APOE and mediates several intracellular sorting and trafficking functions through a VPS10 (vacuolar protein sorting protein 10) domain [<xref rid="pone.0150079.ref036" ref-type="bibr">36</xref>]. SORLA is highly expressed in the brain and modulates APP recycling through the retromer complex, thereby influencing levels of A&#x003b2; [<xref rid="pone.0150079.ref037" ref-type="bibr">37</xref>&#x02013;<xref rid="pone.0150079.ref038" ref-type="bibr">38</xref>]. A growing body of evidence suggested <italic>SORL1</italic> as an excellent positional and functional candidate for AD [<xref rid="pone.0150079.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0150079.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0150079.ref039" ref-type="bibr">39</xref>&#x02013;<xref rid="pone.0150079.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0150079.ref025" ref-type="bibr">25</xref>&#x02013;<xref rid="pone.0150079.ref026" ref-type="bibr">26</xref>]. Moreover, decreased expression and DNA methylation changes at the <italic>SORL1</italic> locus have been reported associated to AD [<xref rid="pone.0150079.ref043" ref-type="bibr">43</xref>&#x02013;<xref rid="pone.0150079.ref044" ref-type="bibr">44</xref>]. <italic>SORL1</italic> harbors 3 of the top variants identified (p.E270K, p.D2065V and p.R11P). Importantly, p.E270K has been reported in 7 Carribean Hispanic families and <italic>in vitro</italic> studies showed that <italic>SORL1</italic> p.E270K is a functional variant, leading to increased secretion of A&#x003b2;, when transfected in HEK293 cell lines and weakening the binding to APP [<xref rid="pone.0150079.ref045" ref-type="bibr">45</xref>]. Therefore, it is plausible that <italic>SORL1</italic> (p.E270K) may increase the susceptibility also for apparently sporadic LOAD. Thus, this finding, with the other main <italic>SORL1</italic> variants detected (p.D2065V and p.R11P) should be further investigated.</p><p>Finally, four of the main hits map to the low-density lipoprotein receptor related protein 1 (LRP1) gene. Importantly, LRP1 is a major A&#x003b2; clearance receptor in cerebral vascular smooth muscle cells and disturbance of this pathway contributes to A&#x003b2; accumulation in the brain [<xref rid="pone.0150079.ref046" ref-type="bibr">46</xref>]. In addition, LRP1 locus was identified as an AD candidate locus in consanguineous Israeli-Arab community [<xref rid="pone.0150079.ref047" ref-type="bibr">47</xref>].</p><p>The c-alpha and SKAT tests reported <italic>ECE1</italic> and <italic>LYZ</italic> and <italic>TTR</italic>, respectively, as main genes associated with LOAD, although after the Bonferroni correction, the association was only nominally significant. Very interestingly, the main genes identified both with the single-marker and gene-based analysis play a pivotal role in the cardiovascular system and have been already signaled as potential risk factors for cerebral amyloid angiopathy (CAA) or vascular dementia [<xref rid="pone.0150079.ref048" ref-type="bibr">48</xref>]. First, <italic>ECE1</italic> and <italic>ACE</italic> are key components of the renin-angiotensin cascade, that controls blood pressure [<xref rid="pone.0150079.ref049" ref-type="bibr">49</xref>]. Second, <italic>ECE1</italic>, <italic>ACE</italic> and <italic>TTR</italic> are mostly expressed by endothelial cells in the CNS (<ext-link ext-link-type="uri" xlink:href="http://web.stanford.edu/group/barres_lab/brain_rnaseq.html">http://web.stanford.edu/group/barres_lab/brain_rnaseq.html</ext-link>). Third, acute and chronic hypoxia, through the release of the hypoxia inducible factor 1&#x003b1; (HIF-1&#x003b1;), exerts a critical epigenetic regulation on APP processing and A&#x003b2; catabolism key genes. Notably, HIF-1&#x003b1; has been reported to increase &#x003b3; and &#x003b2; cleavage of APP and impair A&#x003b2; degradation and clearance mainly through the down regulation of pivotal proteins such as MME, ECE1 and TTR [<xref rid="pone.0150079.ref050" ref-type="bibr">50</xref>&#x02013;<xref rid="pone.0150079.ref053" ref-type="bibr">53</xref>].</p><p>In summary, our study shows that 1) common coding variability within genes involved in APP-A&#x003b2; metabolism does not play a critical role for AD development; 2) genes regulating A&#x003b2; production are more conserved than genes playing a key role in A&#x003b2; degradation and clearance, thus less frequently involved in sporadic AD; 3) <italic>TTR</italic>, <italic>ACE</italic>, <italic>SORL1</italic>, <italic>CTSB</italic> and <italic>LRP1</italic> harbor rare coding variants with strong effect size, likely to be functional and warrant further investigation in an extended cohort; 4) <italic>ECE1</italic>, <italic>LYZ</italic> and <italic>TTR</italic> play a critical role in the cardiovascular system and the joint effect of their variants may increase the susceptibility to AD. Finally, in concert with previous studies, our results support a potential overlapping biology with shared risk factors between CAA, vascular dementia and AD.</p></sec><sec sec-type="supplementary-material" id="sec011"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0150079.s001"><label>S1 Table</label><caption><title>List of the 29 genes selected in our study.</title><p>(DOCX)</p></caption><media xlink:href="pone.0150079.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0150079.s002"><label>S2 Table</label><caption><title>Coding variants detected in APP-A&#x000df; metabolism genes in our study.</title><p>Aa, aminoacid; OR, odds ratio; CI, confidence interval.</p><p>(XLSX)</p></caption><media xlink:href="pone.0150079.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0150079.s003"><label>S3 Table</label><caption><title>Comparison between total variants and relative frequency of variants detected in our study and Exome Variant Server database (EVS) in the European-American cohort.</title><p>(XLSX)</p></caption><media xlink:href="pone.0150079.s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0150079.s004"><label>S4 Table</label><caption><title>Relative frequency of rare variants in the 29 genes analyzed.Kbp, kilobasepair.</title><p>(XLSX)</p></caption><media xlink:href="pone.0150079.s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0150079.s005"><label>S5 Table</label><caption><title>Relative frequency of predicted damaging variants in the 29 genes analyzed.</title><p>The variants have been predicted as damaging by at least 2 out 3 in silico prediction softwares (MUTATION TASTER, SIFT, POLYPHEN2). Kbp, kilobasepair.</p><p>(XLSX)</p></caption><media xlink:href="pone.0150079.s005.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0150079.s006"><label>S6 Table</label><caption><p><bold>A.</bold> Size-matched negative controls for the gene-based association analysis (c-alpha test). <bold>B.</bold> Size-matched negative controls for the gene-based association analysis (SKAT).</p><p>(XLSX)</p></caption><media xlink:href="pone.0150079.s006.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This study was supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023), the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). The MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research are jointly funded from ARUK and AS. The Alzheimer&#x02019;s Research UK (ARUK) Consortium: Peter Passmore, David Craig, Janet Johnston, Bernadette McGuinness, Stephen Todd, Queen&#x02019;s University Belfast, UK; Reinhard Heun, Royal Derby Hospital, UK; Heike K&#x000f6;lsch, University of Bonn, Germany; Patrick G. Kehoe, University of Bristol, UK; Nigel M. Hooper, University of Leeds, UK; Emma R.L.C. Vardy, University of Newcastle, UK; David M. Mann, Stuart Pickering-Brown, University of Manchester, UK; Kristelle Brown, James Lowe, Kevin Morgan, University of Nottingham, UK; A. David Smith, Gordon Wilcock, Donald Warden, University of Oxford (OPTIMA), UK; Clive Holmes, University of Southampton, UK.</p><p>Tissue samples were supplied by The London Neurodegenerative Diseases Brain Bank, which receives funding from the MRC and as part of the Brains for Dementia Research programme, jointly funded by Alzheimer&#x02019;s Research UK and Alzheimer&#x02019;s Society.</p></ack><ref-list><title>References</title><ref id="pone.0150079.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Hardy</surname><given-names>J</given-names></name>, <name><surname>Selkoe</surname><given-names>DJ</given-names></name>. <article-title>The amyloid hypothesis of Alzheimer&#x02019;s disease: progress and problems on the road to therapeutics</article-title>. <source>Science</source>. <year>2002</year><month>7</month>
<day>19</day>;<volume>297</volume>(<issue>5580</issue>):<fpage>353</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 12130773?><pub-id pub-id-type="pmid">12130773</pub-id></mixed-citation></ref><ref id="pone.0150079.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Goate</surname><given-names>A</given-names></name>, <name><surname>Chartier-Harlin</surname><given-names>MC</given-names></name>, <name><surname>Mullan</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>J</given-names></name>, <name><surname>Crawford</surname><given-names>F</given-names></name>, <name><surname>Fidani</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer&#x02019;s disease</article-title>. <source>Nature</source>. <year>1991</year>
<month>2</month>
<day>21</day>;<volume>349</volume>(<issue>6311</issue>):<fpage>704</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 1671712?><pub-id pub-id-type="pmid">1671712</pub-id></mixed-citation></ref><ref id="pone.0150079.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Sherrington</surname><given-names>R</given-names></name>, <name><surname>Rogaev</surname><given-names>EI</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Rogaeva</surname><given-names>EA</given-names></name>, <name><surname>Levesque</surname><given-names>G</given-names></name>, <name><surname>Ikeda</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Cloning of a gene bearing missense mutations in early-onset familial Alzheimer&#x02019;s disease</article-title>. <source>Nature</source>. <year>1995</year>
<month>6</month>
<day>29</day>;<volume>375</volume>(<issue>6534</issue>):<fpage>754</fpage>&#x02013;<lpage>60</lpage>. <?supplied-pmid 7596406?><pub-id pub-id-type="pmid">7596406</pub-id></mixed-citation></ref><ref id="pone.0150079.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Rogaev</surname><given-names>EI</given-names></name>, <name><surname>Sherrington</surname><given-names>R</given-names></name>, <name><surname>Rogaeva</surname><given-names>EA</given-names></name>, <name><surname>Levesque</surname><given-names>G</given-names></name>, <name><surname>Ikeda</surname><given-names>M</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Familial Alzheimer&#x02019;s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer&#x02019;s disease type 3 gene</article-title>. <source>Nature</source>. <year>1995</year>
<month>8</month>
<day>31</day>;<volume>376</volume>(<issue>6543</issue>):<fpage>775</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 7651536?><pub-id pub-id-type="pmid">7651536</pub-id></mixed-citation></ref><ref id="pone.0150079.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Harold</surname><given-names>D</given-names></name>, <name><surname>Abraham</surname><given-names>R</given-names></name>, <name><surname>Hollingworth</surname><given-names>P</given-names></name>, <name><surname>Sims</surname><given-names>R</given-names></name>, <name><surname>Gerrish</surname><given-names>A</given-names></name>, <name><surname>Hamshere</surname><given-names>ML</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer&#x02019;s disease</article-title>. <source>Nat Genet</source>. <year>2009</year>
<month>10</month>;<volume>41</volume>(<issue>10</issue>):<fpage>1088</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.440">10.1038/ng.440</ext-link></comment>
<?supplied-pmid 19734902?><pub-id pub-id-type="pmid">19734902</pub-id></mixed-citation></ref><ref id="pone.0150079.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Lambert</surname><given-names>J-C</given-names></name>, <name><surname>Heath</surname><given-names>S</given-names></name>, <name><surname>Even</surname><given-names>G</given-names></name>, <name><surname>Campion</surname><given-names>D</given-names></name>, <name><surname>Sleegers</surname><given-names>K</given-names></name>, <name><surname>Hiltunen</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer&#x02019;s disease</article-title>. <source>Nat Genet</source>. <year>2009</year>
<month>10</month>;<volume>41</volume>(<issue>10</issue>):<fpage>1094</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.439">10.1038/ng.439</ext-link></comment>
<?supplied-pmid 19734903?><pub-id pub-id-type="pmid">19734903</pub-id></mixed-citation></ref><ref id="pone.0150079.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Seshadri</surname><given-names>S</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>AL</given-names></name>, <name><surname>Ikram</surname><given-names>MA</given-names></name>, <name><surname>DeStefano</surname><given-names>AL</given-names></name>, <name><surname>Gudnason</surname><given-names>V</given-names></name>, <name><surname>Boada</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide analysis of genetic loci associated with Alzheimer disease</article-title>. <source>JAMA J Am Med Assoc</source>. <year>2010</year>
<month>5</month>
<day>12</day>;<volume>303</volume>(<issue>18</issue>):<fpage>1832</fpage>&#x02013;<lpage>40</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Hollingworth</surname><given-names>P</given-names></name>, <name><surname>Harold</surname><given-names>D</given-names></name>, <name><surname>Sims</surname><given-names>R</given-names></name>, <name><surname>Gerrish</surname><given-names>A</given-names></name>, <name><surname>Lambert</surname><given-names>J-C</given-names></name>, <name><surname>Carrasquillo</surname><given-names>MM</given-names></name>, <etal>et al</etal>
<article-title>Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer&#x02019;s disease</article-title>. <source>Nat Genet</source>. <year>2011</year>
<month>5</month>;<volume>43</volume>(<issue>5</issue>):<fpage>429</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.803">10.1038/ng.803</ext-link></comment>
<?supplied-pmid 21460840?><pub-id pub-id-type="pmid">21460840</pub-id></mixed-citation></ref><ref id="pone.0150079.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Naj</surname><given-names>AC</given-names></name>, <name><surname>Jun</surname><given-names>G</given-names></name>, <name><surname>Beecham</surname><given-names>GW</given-names></name>, <name><surname>Wang</surname><given-names>L-S</given-names></name>, <name><surname>Vardarajan</surname><given-names>BN</given-names></name>, <name><surname>Buros</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer&#x02019;s disease</article-title>. <source>Nat Genet</source>. <year>2011</year>
<month>5</month>;<volume>43</volume>(<issue>5</issue>):<fpage>436</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.801">10.1038/ng.801</ext-link></comment>
<?supplied-pmid 21460841?><pub-id pub-id-type="pmid">21460841</pub-id></mixed-citation></ref><ref id="pone.0150079.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Kamboh</surname><given-names>MI</given-names></name>, <name><surname>Demirci</surname><given-names>FY</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Minster</surname><given-names>RL</given-names></name>, <name><surname>Carrasquillo</surname><given-names>MM</given-names></name>, <name><surname>Pankratz</surname><given-names>VS</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association study of Alzheimer&#x02019;s disease</article-title>. <source>Transl Psychiatry</source>. <year>2012</year>;<volume>2</volume>:<fpage>e117</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/tp.2012.45">10.1038/tp.2012.45</ext-link></comment>
<?supplied-pmid 22832961?><pub-id pub-id-type="pmid">22832961</pub-id></mixed-citation></ref><ref id="pone.0150079.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Reitz</surname><given-names>C</given-names></name>, <name><surname>Jun</surname><given-names>G</given-names></name>, <name><surname>Naj</surname><given-names>A</given-names></name>, <name><surname>Rajbhandary</surname><given-names>R</given-names></name>, <name><surname>Vardarajan</surname><given-names>BN</given-names></name>, <name><surname>Wang</surname><given-names>L-S</given-names></name>, <etal>et al</etal>
<article-title>Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E &#x003f5;4,and the risk of late-onset Alzheimer disease in African Americans</article-title>. <source>JAMA J Am Med Assoc</source>. <year>2013</year>
<month>4</month>
<day>10</day>;<volume>309</volume>(<issue>14</issue>):<fpage>1483</fpage>&#x02013;<lpage>92</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Lambert</surname><given-names>J-C</given-names></name>, <name><surname>Ibrahim-Verbaas</surname><given-names>CA</given-names></name>, <name><surname>Harold</surname><given-names>D</given-names></name>, <name><surname>Naj</surname><given-names>AC</given-names></name>, <name><surname>Sims</surname><given-names>R</given-names></name>, <name><surname>Bellenguez</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x02019;s disease</article-title>. <source>Nat Genet</source>. <year>2013</year>
<month>12</month>;<volume>45</volume>(<issue>12</issue>):<fpage>1452</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.2802">10.1038/ng.2802</ext-link></comment>
<?supplied-pmid 24162737?><pub-id pub-id-type="pmid">24162737</pub-id></mixed-citation></ref><ref id="pone.0150079.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Guerreiro</surname><given-names>R</given-names></name>, <name><surname>Wojtas</surname><given-names>A</given-names></name>, <name><surname>Bras</surname><given-names>J</given-names></name>, <name><surname>Carrasquillo</surname><given-names>M</given-names></name>, <name><surname>Rogaeva</surname><given-names>E</given-names></name>, <name><surname>Majounie</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>TREM2 variants in Alzheimer&#x02019;s disease</article-title>. <source>N Engl J Med</source>. <year>2013</year>
<month>1</month>
<day>10</day>;<volume>368</volume>(<issue>2</issue>):<fpage>117</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1211851">10.1056/NEJMoa1211851</ext-link></comment>
<?supplied-pmid 23150934?><pub-id pub-id-type="pmid">23150934</pub-id></mixed-citation></ref><ref id="pone.0150079.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Jonsson</surname><given-names>T</given-names></name>, <name><surname>Stefansson</surname><given-names>H</given-names></name>, <name><surname>Steinberg</surname><given-names>S</given-names></name>, <name><surname>Jonsdottir</surname><given-names>I</given-names></name>, <name><surname>Jonsson</surname><given-names>PV</given-names></name>, <name><surname>Snaedal</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Variant of TREM2 associated with the risk of Alzheimer&#x02019;s disease</article-title>. <source>N Engl J Med</source>. <year>2013</year>
<month>1</month>
<day>10</day>;<volume>368</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02013;<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1211103">10.1056/NEJMoa1211103</ext-link></comment>
<?supplied-pmid 23150908?><pub-id pub-id-type="pmid">23150908</pub-id></mixed-citation></ref><ref id="pone.0150079.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Benitez</surname><given-names>BA</given-names></name>, <name><surname>Karch</surname><given-names>CM</given-names></name>, <name><surname>Cai</surname><given-names>Y</given-names></name>, <name><surname>Jin</surname><given-names>SC</given-names></name>, <name><surname>Cooper</surname><given-names>B</given-names></name>, <name><surname>Carrell</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>The PSEN1, p.E318G variant increases the risk of Alzheimer&#x02019;s disease in APOE-&#x003b5;4 carriers</article-title>. <source>PLoS Genet</source>. <year>2013</year>;<volume>9</volume>(<issue>8</issue>):<fpage>e1003685</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1003685">10.1371/journal.pgen.1003685</ext-link></comment>
<?supplied-pmid 23990795?><pub-id pub-id-type="pmid">23990795</pub-id></mixed-citation></ref><ref id="pone.0150079.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Sassi</surname><given-names>C</given-names></name>, <name><surname>Guerreiro</surname><given-names>R</given-names></name>, <name><surname>Gibbs</surname><given-names>R</given-names></name>, <name><surname>Ding</surname><given-names>J</given-names></name>, <name><surname>Lupton</surname><given-names>MK</given-names></name>, <name><surname>Troakes</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer&#x02019;s disease</article-title>. <source>Neurobiol Aging</source>. <year>2014</year>
<month>6</month>
<day>16</day>;</mixed-citation></ref><ref id="pone.0150079.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Miners</surname><given-names>JS</given-names></name>, <name><surname>Baig</surname><given-names>S</given-names></name>, <name><surname>Palmer</surname><given-names>J</given-names></name>, <name><surname>Palmer</surname><given-names>LE</given-names></name>, <name><surname>Kehoe</surname><given-names>PG</given-names></name>, <name><surname>Love</surname><given-names>S</given-names></name>. <article-title>Abeta-degrading enzymes in Alzheimer&#x02019;s disease</article-title>. <source>Brain Pathol Zurich Switz</source>. <year>2008</year>
<month>4</month>;<volume>18</volume>(<issue>2</issue>):<fpage>240</fpage>&#x02013;<lpage>52</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Selkoe</surname><given-names>DJ</given-names></name>. <article-title>Clearing the brain&#x02019;s amyloid cobwebs</article-title>. <source>Neuron</source>. <year>2001</year>
<month>10</month>
<day>25</day>;<volume>32</volume>(<issue>2</issue>):<fpage>177</fpage>&#x02013;<lpage>80</lpage>. <?supplied-pmid 11683988?><pub-id pub-id-type="pmid">11683988</pub-id></mixed-citation></ref><ref id="pone.0150079.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Ramasamy</surname><given-names>A</given-names></name>, <name><surname>Trabzuni</surname><given-names>D</given-names></name>, <name><surname>Guelfi</surname><given-names>S</given-names></name>, <name><surname>Varghese</surname><given-names>V</given-names></name>, <name><surname>Smith</surname><given-names>C</given-names></name>, <name><surname>Walker</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Genetic variability in the regulation of gene expression in ten regions of the human brain</article-title>. <source>Nat Neurosci</source>. <year>2014</year>
<month>10</month>;<volume>17</volume>(<issue>10</issue>):<fpage>1418</fpage>&#x02013;<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nn.3801">10.1038/nn.3801</ext-link></comment>
<?supplied-pmid 25174004?><pub-id pub-id-type="pmid">25174004</pub-id></mixed-citation></ref><ref id="pone.0150079.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Gibbs</surname><given-names>JR</given-names></name>, <name><surname>van der Brug</surname><given-names>MP</given-names></name>, <name><surname>Hernandez</surname><given-names>DG</given-names></name>, <name><surname>Traynor</surname><given-names>BJ</given-names></name>, <name><surname>Nalls</surname><given-names>MA</given-names></name>, <name><surname>Lai</surname><given-names>S-L</given-names></name>, <etal>et al</etal>
<article-title>Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain</article-title>. <source>PLoS Genet</source>. <year>2010</year>
<month>5</month>;<volume>6</volume>(<issue>5</issue>):<fpage>e1000952</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000952">10.1371/journal.pgen.1000952</ext-link></comment>
<?supplied-pmid 20485568?><pub-id pub-id-type="pmid">20485568</pub-id></mixed-citation></ref><ref id="pone.0150079.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Homer</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinforma Oxf Engl</source>. <year>2009</year>
<month>8</month>
<day>15</day>;<volume>25</volume>(<issue>16</issue>):<fpage>2078</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>McKenna</surname><given-names>A</given-names></name>, <name><surname>Hanna</surname><given-names>M</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Sivachenko</surname><given-names>A</given-names></name>, <name><surname>Cibulskis</surname><given-names>K</given-names></name>, <name><surname>Kernytsky</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>. <source>Genome Res</source>. <year>2010</year>
<month>9</month>;<volume>20</volume>(<issue>9</issue>):<fpage>1297</fpage>&#x02013;<lpage>303</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gr.107524.110">10.1101/gr.107524.110</ext-link></comment>
<?supplied-pmid 20644199?><pub-id pub-id-type="pmid">20644199</pub-id></mixed-citation></ref><ref id="pone.0150079.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Durbin</surname><given-names>R</given-names></name>. <article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinforma Oxf Engl</source>. <year>2009</year>
<month>7</month>
<day>15</day>;<volume>25</volume>(<issue>14</issue>):<fpage>1754</fpage>&#x02013;<lpage>60</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>. <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>
<month>9</month>;<volume>38</volume>(<issue>16</issue>):<fpage>e164</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkq603">10.1093/nar/gkq603</ext-link></comment>
<?supplied-pmid 20601685?><pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation></ref><ref id="pone.0150079.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Rogaeva</surname><given-names>E</given-names></name>, <name><surname>Meng</surname><given-names>Y</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Gu</surname><given-names>Y</given-names></name>, <name><surname>Kawarai</surname><given-names>T</given-names></name>, <name><surname>Zou</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease</article-title>. <source>Nat Genet</source>. <year>2007</year>
<month>2</month>;<volume>39</volume>(<issue>2</issue>):<fpage>168</fpage>&#x02013;<lpage>77</lpage>. <?supplied-pmid 17220890?><pub-id pub-id-type="pmid">17220890</pub-id></mixed-citation></ref><ref id="pone.0150079.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Pottier</surname><given-names>C</given-names></name>, <name><surname>Hannequin</surname><given-names>D</given-names></name>, <name><surname>Coutant</surname><given-names>S</given-names></name>, <name><surname>Rovelet-Lecrux</surname><given-names>A</given-names></name>, <name><surname>Wallon</surname><given-names>D</given-names></name>, <name><surname>Rousseau</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease</article-title>. <source>Mol Psychiatry</source>. <year>2012</year>
<month>9</month>;<volume>17</volume>(<issue>9</issue>):<fpage>875</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mp.2012.15">10.1038/mp.2012.15</ext-link></comment>
<?supplied-pmid 22472873?><pub-id pub-id-type="pmid">22472873</pub-id></mixed-citation></ref><ref id="pone.0150079.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Li</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Ma</surname><given-names>G</given-names></name>, <name><surname>Shang</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer&#x02019;s disease susceptibility</article-title>. <source>Mol Neurobiol</source>. <year>2014</year>
<month>12</month>;<volume>50</volume>(<issue>3</issue>):<fpage>757</fpage>&#x02013;<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12035-014-8670-4">10.1007/s12035-014-8670-4</ext-link></comment>
<?supplied-pmid 24643655?><pub-id pub-id-type="pmid">24643655</pub-id></mixed-citation></ref><ref id="pone.0150079.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Steinberg</surname><given-names>S</given-names></name>, <name><surname>Stefansson</surname><given-names>H</given-names></name>, <name><surname>Jonsson</surname><given-names>T</given-names></name>, <name><surname>Johannsdottir</surname><given-names>H</given-names></name>, <name><surname>Ingason</surname><given-names>A</given-names></name>, <name><surname>Helgason</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Loss-of-function variants in ABCA7 confer risk of Alzheimer&#x02019;s disease</article-title>. <source>Nat Genet</source>. <year>2015</year>
<month>3</month>
<day>25</day>;</mixed-citation></ref><ref id="pone.0150079.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>R</given-names></name>, <name><surname>Gon&#x000e7;alves</surname><given-names>A</given-names></name>, <name><surname>Saraiva</surname><given-names>MJ</given-names></name>, <name><surname>Cardoso</surname><given-names>I</given-names></name>. <article-title>Transthyretin binding to A-Beta peptide&#x02014;impact on A-Beta fibrillogenesis and toxicity</article-title>. <source>FEBS Lett</source>. <year>2008</year>
<month>3</month>
<day>19</day>;<volume>582</volume>(<issue>6</issue>):<fpage>936</fpage>&#x02013;<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.febslet.2008.02.034">10.1016/j.febslet.2008.02.034</ext-link></comment>
<?supplied-pmid 18295603?><pub-id pub-id-type="pmid">18295603</pub-id></mixed-citation></ref><ref id="pone.0150079.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Cuenco</surname><given-names>KT</given-names></name>, <name><surname>Friedland</surname><given-names>R</given-names></name>, <name><surname>Baldwin</surname><given-names>CT</given-names></name>, <name><surname>Guo</surname><given-names>J</given-names></name>, <name><surname>Vardarajan</surname><given-names>B</given-names></name>, <name><surname>Lunetta</surname><given-names>KL</given-names></name>, <etal>et al</etal>
<article-title>Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families</article-title>. <source>Neurobiol Aging</source>. <year>2011</year>
<month>2</month>;<volume>32</volume>(<issue>2</issue>):<fpage>249</fpage>&#x02013;<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neurobiolaging.2009.02.014">10.1016/j.neurobiolaging.2009.02.014</ext-link></comment>
<?supplied-pmid 19328595?><pub-id pub-id-type="pmid">19328595</pub-id></mixed-citation></ref><ref id="pone.0150079.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>SH</given-names></name>, <name><surname>Leight</surname><given-names>SN</given-names></name>, <name><surname>Lee</surname><given-names>VM-Y</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Wong</surname><given-names>PC</given-names></name>, <name><surname>Johnson</surname><given-names>JA</given-names></name>, <etal>et al</etal>
<article-title>Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin)</article-title>. <source>J Neurosci Off J Soc Neurosci</source>. <year>2007</year>
<month>6</month>
<day>27</day>;<volume>27</volume>(<issue>26</issue>):<fpage>7006</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Wati</surname><given-names>H</given-names></name>, <name><surname>Kawarabayashi</surname><given-names>T</given-names></name>, <name><surname>Matsubara</surname><given-names>E</given-names></name>, <name><surname>Kasai</surname><given-names>A</given-names></name>, <name><surname>Hirasawa</surname><given-names>T</given-names></name>, <name><surname>Kubota</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer&#x02019;s disease</article-title>. <source>Brain Pathol Zurich Switz</source>. <year>2009</year>
<month>1</month>;<volume>19</volume>(<issue>1</issue>):<fpage>48</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>K</given-names></name>, <name><surname>Maeda</surname><given-names>T</given-names></name>, <name><surname>Watanabe</surname><given-names>A</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Oba</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme</article-title>. <source>J Biol Chem</source>. <year>2009</year>
<month>11</month>
<day>13</day>;<volume>284</volume>(<issue>46</issue>):<fpage>31914</fpage>&#x02013;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M109.011437">10.1074/jbc.M109.011437</ext-link></comment>
<?supplied-pmid 19773553?><pub-id pub-id-type="pmid">19773553</pub-id></mixed-citation></ref><ref id="pone.0150079.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>J</given-names></name>, <name><surname>Igarashi</surname><given-names>A</given-names></name>, <name><surname>Kamata</surname><given-names>M</given-names></name>, <name><surname>Nakagawa</surname><given-names>H</given-names></name>. <article-title>Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity</article-title>. <source>J Biol Chem</source>. <year>2001</year>
<month>12</month>
<day>21</day>;<volume>276</volume>(<issue>51</issue>):<fpage>47863</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 11604391?><pub-id pub-id-type="pmid">11604391</pub-id></mixed-citation></ref><ref id="pone.0150079.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Hemming</surname><given-names>ML</given-names></name>, <name><surname>Selkoe</surname><given-names>DJ</given-names></name>. <article-title>Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor</article-title>. <source>J Biol Chem</source>. <year>2005</year>
<month>11</month>
<day>11</day>;<volume>280</volume>(<issue>45</issue>):<fpage>37644</fpage>&#x02013;<lpage>50</lpage>. <?supplied-pmid 16154999?><pub-id pub-id-type="pmid">16154999</pub-id></mixed-citation></ref><ref id="pone.0150079.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Yamazaki</surname><given-names>H</given-names></name>, <name><surname>Bujo</surname><given-names>H</given-names></name>, <name><surname>Kusunoki</surname><given-names>J</given-names></name>, <name><surname>Seimiya</surname><given-names>K</given-names></name>, <name><surname>Kanaki</surname><given-names>T</given-names></name>, <name><surname>Morisaki</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member</article-title>. <source>J Biol Chem</source>. <year>1996</year>
<month>10</month>
<day>4</day>;<volume>271</volume>(<issue>40</issue>):<fpage>24761</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 8798746?><pub-id pub-id-type="pmid">8798746</pub-id></mixed-citation></ref><ref id="pone.0150079.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>OM</given-names></name>, <name><surname>Reiche</surname><given-names>J</given-names></name>, <name><surname>Schmidt</surname><given-names>V</given-names></name>, <name><surname>Gotthardt</surname><given-names>M</given-names></name>, <name><surname>Spoelgen</surname><given-names>R</given-names></name>, <name><surname>Behlke</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>
<month>9</month>
<day>20</day>;<volume>102</volume>(<issue>38</issue>):<fpage>13461</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 16174740?><pub-id pub-id-type="pmid">16174740</pub-id></mixed-citation></ref><ref id="pone.0150079.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Offe</surname><given-names>K</given-names></name>, <name><surname>Dodson</surname><given-names>SE</given-names></name>, <name><surname>Shoemaker</surname><given-names>JT</given-names></name>, <name><surname>Fritz</surname><given-names>JJ</given-names></name>, <name><surname>Gearing</surname><given-names>M</given-names></name>, <name><surname>Levey</surname><given-names>AI</given-names></name>, <etal>et al</etal>
<article-title>The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments</article-title>. <source>J Neurosci Off J Soc Neurosci</source>. <year>2006</year>
<month>2</month>
<day>1</day>;<volume>26</volume>(<issue>5</issue>):<fpage>1596</fpage>&#x02013;<lpage>603</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Feulner</surname><given-names>TM</given-names></name>, <name><surname>Laws</surname><given-names>SM</given-names></name>, <name><surname>Friedrich</surname><given-names>P</given-names></name>, <name><surname>Wagenpfeil</surname><given-names>S</given-names></name>, <name><surname>Wurst</surname><given-names>SHR</given-names></name>, <name><surname>Riehle</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Examination of the current top candidate genes for AD in a genome-wide association study</article-title>. <source>Mol Psychiatry</source>. <year>2010</year>
<month>7</month>;<volume>15</volume>(<issue>7</issue>):<fpage>756</fpage>&#x02013;<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mp.2008.141">10.1038/mp.2008.141</ext-link></comment>
<?supplied-pmid 19125160?><pub-id pub-id-type="pmid">19125160</pub-id></mixed-citation></ref><ref id="pone.0150079.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Miyashita</surname><given-names>A</given-names></name>, <name><surname>Koike</surname><given-names>A</given-names></name>, <name><surname>Jun</surname><given-names>G</given-names></name>, <name><surname>Wang</surname><given-names>L-S</given-names></name>, <name><surname>Takahashi</surname><given-names>S</given-names></name>, <name><surname>Matsubara</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>SORL1 is genetically associated with late-onset Alzheimer&#x02019;s disease in Japanese, Koreans and Caucasians</article-title>. <source>PloS One</source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e58618</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0058618">10.1371/journal.pone.0058618</ext-link></comment>
<?supplied-pmid 23565137?><pub-id pub-id-type="pmid">23565137</pub-id></mixed-citation></ref><ref id="pone.0150079.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>EK</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>CP</given-names></name>, <name><surname>Teo</surname><given-names>YY</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Lee</surname><given-names>WL</given-names></name>. <article-title>SORL1 haplotypes modulate risk of Alzheimer&#x02019;s disease in Chinese</article-title>. <source>Neurobiol Aging</source>. <year>2009</year>
<month>7</month>;<volume>30</volume>(<issue>7</issue>):<fpage>1048</fpage>&#x02013;<lpage>51</lpage>. <?supplied-pmid 18063222?><pub-id pub-id-type="pmid">18063222</pub-id></mixed-citation></ref><ref id="pone.0150079.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Cheng</surname><given-names>R</given-names></name>, <name><surname>Schupf</surname><given-names>N</given-names></name>, <name><surname>Manly</surname><given-names>J</given-names></name>, <name><surname>Lantigua</surname><given-names>R</given-names></name>, <name><surname>Stern</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort</article-title>. <source>Arch Neurol</source>. <year>2007</year>
<month>4</month>;<volume>64</volume>(<issue>4</issue>):<fpage>501</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 17420311?><pub-id pub-id-type="pmid">17420311</pub-id></mixed-citation></ref><ref id="pone.0150079.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Scherzer</surname><given-names>CR</given-names></name>, <name><surname>Offe</surname><given-names>K</given-names></name>, <name><surname>Gearing</surname><given-names>M</given-names></name>, <name><surname>Rees</surname><given-names>HD</given-names></name>, <name><surname>Fang</surname><given-names>G</given-names></name>, <name><surname>Heilman</surname><given-names>CJ</given-names></name>, <etal>et al</etal>
<article-title>Loss of apolipoprotein E receptor LR11 in Alzheimer disease</article-title>. <source>Arch Neurol</source>. <year>2004</year>
<month>8</month>;<volume>61</volume>(<issue>8</issue>):<fpage>1200</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 15313836?><pub-id pub-id-type="pmid">15313836</pub-id></mixed-citation></ref><ref id="pone.0150079.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>L</given-names></name>, <name><surname>Chibnik</surname><given-names>LB</given-names></name>, <name><surname>Srivastava</surname><given-names>GP</given-names></name>, <name><surname>Pochet</surname><given-names>N</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease</article-title>. <source>JAMA Neurol</source>. <year>2015</year>
<month>1</month>;<volume>72</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jamaneurol.2014.3049">10.1001/jamaneurol.2014.3049</ext-link></comment>
<?supplied-pmid 25365775?><pub-id pub-id-type="pmid">25365775</pub-id></mixed-citation></ref><ref id="pone.0150079.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Vardarajan</surname><given-names>BN</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Cheng</surname><given-names>R</given-names></name>, <name><surname>Bohm</surname><given-names>C</given-names></name>, <name><surname>Ghani</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Coding mutations in SORL1 and Alzheimer disease</article-title>. <source>Ann Neurol</source>. <year>2015</year>
<month>2</month>;<volume>77</volume>(<issue>2</issue>):<fpage>215</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ana.24305">10.1002/ana.24305</ext-link></comment>
<?supplied-pmid 25382023?><pub-id pub-id-type="pmid">25382023</pub-id></mixed-citation></ref><ref id="pone.0150079.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Kanekiyo</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>C-C</given-names></name>, <name><surname>Shinohara</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Bu</surname><given-names>G</given-names></name>. <article-title>LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer&#x02019;s amyloid-&#x003b2;</article-title>. <source>J Neurosci Off J Soc Neurosci</source>. <year>2012</year>
<month>11</month>
<day>14</day>;<volume>32</volume>(<issue>46</issue>):<fpage>16458</fpage>&#x02013;<lpage>65</lpage>.</mixed-citation></ref><ref id="pone.0150079.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Farrer</surname><given-names>LA</given-names></name>, <name><surname>Bowirrat</surname><given-names>A</given-names></name>, <name><surname>Friedland</surname><given-names>RP</given-names></name>, <name><surname>Waraska</surname><given-names>K</given-names></name>, <name><surname>Korczyn</surname><given-names>AD</given-names></name>, <name><surname>Baldwin</surname><given-names>CT</given-names></name>. <article-title>Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community</article-title>. <source>Hum Mol Genet</source>. <year>2003</year>
<month>2</month>
<day>15</day>;<volume>12</volume>(<issue>4</issue>):<fpage>415</fpage>&#x02013;<lpage>22</lpage>. <?supplied-pmid 12566388?><pub-id pub-id-type="pmid">12566388</pub-id></mixed-citation></ref><ref id="pone.0150079.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Revesz</surname><given-names>T</given-names></name>, <name><surname>Holton</surname><given-names>JL</given-names></name>, <name><surname>Lashley</surname><given-names>T</given-names></name>, <name><surname>Plant</surname><given-names>G</given-names></name>, <name><surname>Frangione</surname><given-names>B</given-names></name>, <name><surname>Rostagno</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies</article-title>. <source>Acta Neuropathol (Berl)</source>. <year>2009</year>
<month>7</month>;<volume>118</volume>(<issue>1</issue>):<fpage>115</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">19225789</pub-id></mixed-citation></ref><ref id="pone.0150079.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Rossi</surname><given-names>GP</given-names></name>, <name><surname>Sacchetto</surname><given-names>A</given-names></name>, <name><surname>Cesari</surname><given-names>M</given-names></name>, <name><surname>Pessina</surname><given-names>AC</given-names></name>. <article-title>Interactions between endothelin-1 and the renin-angiotensin-aldosterone system</article-title>. <source>Cardiovasc Res</source>. <year>1999</year>
<month>8</month>
<day>1</day>;<volume>43</volume>(<issue>2</issue>):<fpage>300</fpage>&#x02013;<lpage>7</lpage>. <?supplied-pmid 10536660?><pub-id pub-id-type="pmid">10536660</pub-id></mixed-citation></ref><ref id="pone.0150079.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Nalivaevaa</surname><given-names>NN</given-names></name>, <name><surname>Fisk</surname><given-names>L</given-names></name>, <name><surname>Kochkina</surname><given-names>EG</given-names></name>, <name><surname>Plesneva</surname><given-names>SA</given-names></name>, <name><surname>Zhuravin</surname><given-names>IA</given-names></name>, <name><surname>Babusikova</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes</article-title>. <source>Ann N Y Acad Sci</source>. <year>2004</year>
<month>12</month>;<volume>1035</volume>:<fpage>21</fpage>&#x02013;<lpage>33</lpage>. <?supplied-pmid 15681798?><pub-id pub-id-type="pmid">15681798</pub-id></mixed-citation></ref><ref id="pone.0150079.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Nalivaeva</surname><given-names>NN</given-names></name>, <name><surname>Belyaev</surname><given-names>ND</given-names></name>, <name><surname>Kerridge</surname><given-names>C</given-names></name>, <name><surname>Turner</surname><given-names>AJ</given-names></name>. <article-title>Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer&#x02019;s disease</article-title>. <source>Front Aging Neurosci</source>. <year>2014</year>;<volume>6</volume>:<fpage>235</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fnagi.2014.00235">10.3389/fnagi.2014.00235</ext-link></comment>
<?supplied-pmid 25278875?><pub-id pub-id-type="pmid">25278875</pub-id></mixed-citation></ref><ref id="pone.0150079.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Yang</surname><given-names>D</given-names></name>, <name><surname>Luo</surname><given-names>G</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Le</surname><given-names>W</given-names></name>. <article-title>Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP</article-title>. <source>Neurobiol Aging</source>. <year>2009</year>
<month>7</month>;<volume>30</volume>(<issue>7</issue>):<fpage>1091</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 18063223?><pub-id pub-id-type="pmid">18063223</pub-id></mixed-citation></ref><ref id="pone.0150079.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Yang</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Tang</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons</article-title>. <source>PloS One</source>. <year>2011</year>;<volume>6</volume>(<issue>4</issue>):<fpage>e19229</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0019229">10.1371/journal.pone.0019229</ext-link></comment>
<?supplied-pmid 21559427?><pub-id pub-id-type="pmid">21559427</pub-id></mixed-citation></ref></ref-list></back></article>